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 Abstract 
 
Aims: The cornea is a tough, transparent tissue providing the primary refractive 
element of the eye. The stroma consists of specially arranged collagen required for 
corneal transparency. Correct stromal hydration is important in the maintenance of 
transparency, a feature controlled by the endothelial cells on the posterior surface of 
the cornea. The aims of this research were firstly to investigate the morphology of 
corneal endothelial cells and their expression of the sodium bicarbonate cotransporter 
during avian embryonic development and secondly, to clarify the effect of disease, 
surgery and drugs on the posterior cornea including in particular the corneal 
endothelium.  
 
Methods: The corneal endothelial cell morphology and posterior stroma were 
examined using transmission electron microscopy to determine the ultrastructure of 
the cells and collagen fibril arrangement in the stroma in all results chapters. 
Immunohistochemistry and A-scan ultrasonography were employed to identify the 
presence of the Na
+
HCO3
-
 cotransporter and to determine the thickness changes in 
embryonic chick cornea, respectively. Electron tomography was also used to 
determine the collagen arrangement in Descemet’s membrane.  
 
Results: The expression of the Na
+
HCO3
-
 cotransporter was identified in the 
endothelial layer of the embryonic chicks at all stages imaged. Central corneal 
thickness increased in the initial stages of development before a plateau between the 
E12-E15 developmental period followed by a steady thickness decrease. The 
ultrastructure of Descemet’s membrane was determined using electron tomography of 
transverse and en face resin embedded sections from which a model was produced. 
Polygonal and elongated structures were observed with proteoglycans present at the 
intermodal regions of the collagenous structures. The polygonal lattice visualised in 
en face sections appeared to be composed of stacked globular domains which were 
integrated into the collagen type VIII model. Predominant changes in the Col8a2 
knock-in mouse models were observed in the posterior cornea. Differences included 
increased proteoglycans at the Descemet’s endothelial interface, dilated rough 
endoplasmic reticulum and focal posterior oedema. This animal model exhibits 
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features similar to those seen in the human form of early-onset Fuchs’ endothelial 
corneal dystrophy, unlike previous models reported. The final chapter is concerned 
with regeneration of the corneal endothelial cells. Tissue from posterior corneal 
surgery examined using electron microscopy revealed the presence of the host 
endothelial cells and fibrous tissue at the interface in non-Descemet’s membrane 
stripping automated endothelial keratoplasty and interface haze in Descemet’s 
membrane stripping automated endothelial keratoplasty. However, these features did 
not appear to interfere with the adhesion of the graft nor the clarity.  
 
Finally, ultrastructural analysis of Rho-kinase inhibited cells showed cells with typical 
morphology when compared with the untreated group 
 
Conclusions: 1) The Na
+
HCO3
- 
cotransporter is present in the embryonic cornea. It is 
possible that the cotransporter is involved in the developmental stages and probably 
the thickness changes we observe during this period. 2) The ultrastructure of 
Descemet’s membrane appears to be composed of stacked globular domains arranged 
in a polygonal lattice alongside more elongated structures interspersed with 
proteoglycans within the internodal regions. 3) Our studies have helped validate 
Col4a2 mice as a promising Fuchs’ endothelial corneal dystrophy model. 4) Our 
investigation into posterior corneal surgery revealed ultrastructural changes that occur 
post-surgery at the graft interface.  
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1. 
 
The cornea is a transparent, tough, connective tissue providing the primary refractive 
element within the eye. This tissue is responsible for more than two thirds of the eye’s 
dioptric power (42.4 Dioptres), the remainder of which is provided by the crystalline 
lens, controlled by the muscles of the ciliary body. Together with the sclera and 
limbus, the cornea forms a protective envelope enclosing the ocular tissue (Figure 
1.1). Collagen fibrils constitute the principal components of the cornea and sclera, 
conferring rigidity and protection; however, these tissues are remarkably different in 
collagen organisation resulting in corneal transparency and scleral opaqueness. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1 The Cornea: Structure and Function  
 
The cornea (Figure 1.2) is comprised of five main layers; an outer epithelium anterior 
to Bowman’s layer, the corneal stroma, Descemet’s membrane and most posterior, the 
corneal endothelium. Corneal avascularity and the regular arrangement of the 
collagen fibrils within the stroma are essential for corneal clarity. Oxygen is 
predominantly obtained from the tear film, whilst nutrients originate from the aqueous 
humour that bathes the endothelium. The tear film also plays a role in protection 
against microbes and pathogens that come into contact with the anterior surface by 
producing immunoglobulins and antimicrobials. It also provides a clear refractive 
interface for the cornea, filling depressions present in the epithelial layer.  
Limbus 
Figure 1.1 Cross section schematic of human eye. Adapted from http://www.royles-
opticians.co.uk/glossary.shtml 
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1.2 Corneal Epithelium 
 
The corneal epithelium is a stratified, non-keratinised layer between five and six cells 
thick that is continuous with the conjunctiva at the corneal limbus. The layer is 
composed of three cell types, the outermost superficial cells, wing cells and finally 
basal cells, the innermost layer in which mitosis occurs. Older epithelial cells move 
toward the surface of the cornea and are replaced by daughter cells that become more 
differentiated with time. Cells eventually degenerate and are shed from the corneal 
surface, a process resulting in replacement of the entire epithelium every seven days 
(Hanna et al, 1961) from limbal stem cells (Davanger and Evensen, 1971; Dua and 
Azuara-Blanco, 2000). These stem cells are located in the basal region of the limbus 
and divide to produce the daughter transit amplifying cells that migrate to populate 
the epithelium basal layer. These cells differentiate, eventually becoming post-mitotic 
terminally differentiated cells. In development the corneal epithelium is responsible 
for secreting the primary stroma (Hay and Dodson, 1973), a collagenous matrix 
comprising of collagen types I and II (Linsenmeyer et al, 1977; Von der Mark et al, 
1977) that appears on embryonic day 3 (E3) in the avian cornea. (Hay and Revel, 
1969). The basal cells of the epithelium lie on and produce a basement membrane, 40-
60nm thick, anterior to Bowman’s layer (Kenyon, 1969). The basal lamina is 
composed of collagen and glycoproteins, whilst short anchoring filaments attach it 
firmly to Bowman’s membrane on its posterior surface.  
Figure 1.2 Cross-section of cornea.  
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1.3 Bowman’s Layer 
 
Bowman’s layer is an acellular, 8-14µm thick zone posterior to the basal lamina. This 
layer is present in primates but absent in many species inluding cats, dogs, mice and 
other carnivores (Calmettes et al, 1956). The layer is composed of type I, III, V and 
VII collagen (Gordon et al, 1994; Nakayasu et al, 1986) of uniform size which 
become more ordered in the posterior region of Bowman’s. These fibrils are thinner 
than those present in the stroma and their compact arrangement confers strength to 
this layer helping its resistance to trauma. Anterior Bowman’s is smooth, whilst 
posteriorly it fuses indistinctly with collagen in the stroma.  
 
1.4 Stroma 
 
The stroma is a dense, regularly packed structure of collagen fibrils arranged as 
orthogonal layers or lamellae (200-300 centrally) that lie within a proteoglycan matrix 
interspersed with keratocytes. The stroma constitutes around 90% of the cornea’s 
thickness, measuring around 500 µm in man. Lamellae consist of small diameter 
collagen fibrils (25-30 nm) whose arrangement allows minimal light scattering, 
permitting transparency. The stroma is made up of predominantly type I collagen, 
each layer between 1.5-2.5 µm thick. Keratocytes occupy 2.5-5% of the stroma 
(Smelser and Ozanics 1965), these are mesenchymal-derived cells responsible for the 
synthesis of stromal collagen and wound healing. Stromal repair involves activation 
of keratocytes and production of scar tissue.  
 
1.4.1 Collagen 
 
Collagen is the main component of connective tissue present in tendon, ligament, 
skin, cornea, cartilage, bone and blood vessels. Collagen has a unique structure 
composed of three polypeptide chains assembling into a triple-helical arrangement. 
Corneal collagen fibrils are organised into layers referred to as lamellae in which 
collagen fibrils tend to be aligned in the same direction, surrounded by proteoglycans. 
The three polypeptide chains (α-chains) are made up of a sequence of amino acids 
characterised by the repeating motif G-X-Y, where G represents glycine. The 
presence of glycine, the smallest amino acid, at every third position is important for 
Chapter 1: Introduction  
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the formation of the triple helix. Biosynthesis of fibril-forming collagens begins when 
collagen polypeptide chains are synthesised on the ribosomes of the rough 
endoplasmic reticulum (RER) before being moved into its lumen. Here, they undergo 
triple helix formation before the procollagen molecule (precursor form) is secreted 
into the extracellular matrix (ECM) for enzyme modification. Specific proteases 
cleave the N- and C- propeptides on the globular ends (Kielty and Grant, 2003) 
(Figure 1.3) allowing the molecules to associate into fibrils (Kadler et al, 1987) that in 
turn assemble into collagen fibres. The presence of the globular ends prevents 
aggregation and fibril assembly occurring intracellularly. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corneal transparency is due primarily to the uniformly small diameter (25 nm) of 
collagen fibrils and their regular interspacing. Collagen types I, III, and V assemble 
into cross striated fibrils whose molecules have staggered ends at one-quarter of their 
Figure 1.3 Schematic of the steps involved in collagen biosynthesis. Collagen polypeptide synthesis 
and triple helix formation occurs in the RER prior to secretion of the procollagen into secretory 
vesicles. Once in the ECM, proteases cleave the N and C propeptides before fibril formation (Taken 
from Kielty and Grant, 2003) 
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length referred to as the ‘quarter staggered array’. D periodicity (Chapman et al, 
1990) results from molecules in a quarter staggered assembly. The D period has a 
value of 67 nm (65 nm in cornea) and is comprised of a gap (4 molecules) and an 
overlap (5 molecules) region. Staining with a heavy metal under transmission electron 
microscopy (TEM) shows the banding pattern present in the D period, displaying five 
staining zones labelled a-e (Figure 1.4). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4.1.1 Fibril Forming Collagens 
 
Fibril-forming collagens consist of an uninterrupted triple helix synthesised as 
procollagen molecules that undergo processing to assemble into collagen fibrils. The 
major fibrillar collagens are long, unbranched and have a periodicity of between 60-
70 nm. 
 
Type I collagen is an abundant heterotrimeric fibrillar collagen composed of two α1 
chains and one α2 chain (Piez et al, 1963). It is not only found in primary 
(Linsenmayer et al, 1977) and secondary cornea but also in many other adult 
connective tissues. Type I collagen molecules are 300  nm long with a diameter of 1.5 
Figure 1.4 Collagen fibril structure. (a) Collagen arrangement includes gap and overlap regions that 
represent the D period. The light and dark regions observed in (b) indicate the preferential stain 
penetration. (c) Darkly stained areas are the result of the uptake of electron-dense heavy metal ions 
from the stain (Chapman et al, 1990).  
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nm. Type I collagen is essential for corneal tensile strength and for the establishment 
of normal stromal organisation, this is demonstrated by Mov13 mutant mice where a 
lack of collagen type I results in thin fibrils with no orthogonal arrangement (Bard and 
Kratochwil, 1987). In the avian cornea there is strong evidence that collagen type I 
forms heterotypic fibrils with collagen type II during development and with type V 
collagen in mature stroma (Hendrix et al, 1982).  
 
Type II is a homotrimeric collagen consisting of three identical α1(II) chains, present 
in the primary stroma of embryonic chick (Linsenmayer et al, 1977). Type II collagen 
is converted into fibrils within the primary stroma (Chen et al, 1993). Type II collagen 
mRNA was also detected after cell invasion, thought to function as a template for 
corneal growth (Linsenmayer et al, 1990). Synthesis of type II is superseded by 
collagen type I synthesis by mesenchymal cells post E10.  
 
One of the most heterogeneous collagens is type V, the most common isoform 
comprising of α1(V)2 α2(V) is present in the cornea (Birk et al, 1988). The 
appearance of type V collagen has been shown to coincide with mesenchyme invasion 
(Linsenmayer et al, 1984) and is coassembled with type I collagen. Types I and V 
form heterotypic structures (Fitch et al, 1984; Birk et al, 1988) that help to regulate 
fibril diameter within the cornea (Birk et al 1990).  
 
1.4.1.2 Non-Fibrillar Collagens 
 
1.4.1.2.1 FACIT Collagens 
 
Fibril associated collagens with interrupted triple helices (FACIT) are a family of 
collagens including type IX, XII, XIV, XVI, XIX and XX (Gordon et al 1989). 
FACIT collagens are capable of interacting with fibrillar collagens, characterised by 
short triple helices interrupted by non-collagenous sequences (Kielty and Grant, 
2003).  
 
Type IX is a major FACIT collagen present in the early developing chick cornea 
(Fitch et al, 1988; Svoboda et al, 1988). There is a decrease in type IX collagen prior 
to stromal invasion by mesenchymal cells (Fitch et al, 1988; Cai et al, 1994) and by 
Chapter 1: Introduction  
20 
 
E11 it is undetectable. Type IX is thought to act as a stabilising factor concerned with 
keeping the primary stroma in a compact form. As a result, when type IX collagen is 
removed mesenchymal cells are able to invade the tissue and construct the secondary 
stroma (Cai et al, 1994).  
 
1.4.1.2.2 Short Chain Collagens 
 
Type VI is a short chain collagen comprised of short triple helical domains (105 nm) 
which come together to form tetramers. Dimers are formed by lateral aggregation of 
anti-parallel monomers; these align to form tetramers whose structures aggregate end-
to-end resulting in long, thin, beaded filamentous structures (Kielty and Grant, 2003). 
 
Type VIII collagen is a non-fibrillar short chain collagen originally identified as a 
product of endothelial cells from bovine aorta and rabbit cornea (Sage et al, 1983). It 
is a major component of Descemet’s membrane, made up of two distinct α-chains 
forming heterotrimers (α1(VIII)2 α2(VIII)). A collagen type VIII hexagonal lattice is 
observed in Descemet’s (Sawada et al, 1990) which is arranged in stacks parallel to 
the surface of the membrane (Figure 1.5). Rotary shadowing images show a 132.5 nm 
long, rod shaped structure with large and small domains at either end. These globular 
regions are the non-collagenous domains, whilst the filamentous structures represent 
the triple helices (Shuttleworth, 1997). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Hexagonal lattice present in Descemet’s membrane. Type VIII collagen forms open 
hexagonal arrays that are stacked in parallel to the surface of the membrane. Rotary shadowing 
imaging shows a rod like structure measuring 132.5 nm Taken from Shuttleworth, 1997; Kielty and 
Grant, 2003. 
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  1.4.2 Proteoglycans 
 
Proteoglycans have been implicated in cell motility, adhesion, differentiation and 
morphogenesis. They are present in connective tissue, on cell surfaces and in 
extracellular matrices. Proteoglycans are also present within the stroma. They are 
small in size (approx. 50kDa) allowing them to fit into the spaces between the 
collagen fibrils which helps to regulate spacing (Cintron et al, 1978; Hassell et al, 
1983). Proteoglycans consist of a core protein (25-450kDa) with one or more 
covalently attached glycosaminoglycan (GAG) chains, by which they are named and 
grouped. 
 
Proteoglycans present in the stroma belong to the small leucine-rich proteoglycan 
(SLRP) family that interact with fibrillar collagens to achieve correct collagen 
spacing. The leucine-rich repeats make up the central part of each protein flanked by 
cysteine-rich regions. Another dimension is the attachment of one or more GAG 
chains.  The current theory suggests that the core proteins of the proteoglycans bind to 
the surface of collagen fibrils to help modulate interfibrillar spacing (Scott, 1996). 
Proteoglycan synthesis involves precursor protein release into the RER before being 
processed in the Golgi, involving the addition of the GAG chains. The fate of the 
proteoglycan is then dependent on the tissue and the proteoglycan itself. For example, 
some proteoglycans will be secreted into the extracellular matrix where they become 
structural components, others can be deposited on the cell surface as a membrane 
component (Hassell et al, 1986). 
 
1.4.3 Glycosaminoglycans 
 
GAGs are a class of biological macromolecules that are major structural components 
of proteoglycans. GAGs are linear polysaccharides composed of repeating 
disaccharide units in which the disaccharide building blocks consist of an amino sugar 
and a uronic acid or galactose. The predominant corneal GAG side chains are 
chondroitin sulphate/dermatan sulphate (CS/DS), keratan sulphate (KS) and smaller 
amounts of heparan sulphate (Hassell et al, 1986). Sulphate groups present on GAG 
chains bind water. At the correct hydration present in normal cornea, CS/DS chains 
are fully hydrated whilst KS chains are not. These may act as a reserve for hydration 
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(Bettelheim and Plessy, 1975). GAGs carry a very high negative charge density 
provided by the sulphate and uronic acid at physiological pH (Gandhi and Mancera, 
2008). The negative charge on the sulphate group allows proteoglycans to make ionic 
interactions with arginines, lysines and histidines on the surface of proteins.  
 
1.4.3.1 Keratan Sulphate  
 
KS is the major GAG in the corneal stroma regulating matrix architecture (Anseth, 
1961; Funderburgh et al, 1986). In the cornea, KS is present on three SLRPs, lumican 
(Blochberger et al, 1992), keratocan, and mimecan (Corpuz et al, 1996). Electron 
microscopy on bovine cornea revealed KS proteoglycans are 40 nm long (Scott, 1992) 
and capable of fitting in between (Hassell et al, 1983) and interacting with collagen 
fibrils (Scott and Haigh, 1985). Corneal KS consists of repeating N-
acetylglucosamine and galactose units, linked to an asparagine residue in the core 
protein (Figure 1.6). KS is only partially hydrated, suggesting it plays a role in 
buffering corneal hydration. Lumican is one of the major corneal KS proteoglycans 
with an abundant amount of mRNA (Blochberger et al, 1992), suggesting it has an 
important role. The leucine rich repeat region allows lumican to interact with collagen 
fibrils to modulate fibril formation whilst the GAG chains extend out to regulate 
interfibrillar spacing (Weber at al, 1996). The importance of KS is seen in 
homogenous lumican knockouts that show altered collagenous matrix characteristics 
including disorganised collagen spacing and larger fibril diameter (Chakravarti et al, 
1998). However, keratocan knockouts result in thinner corneas but show no 
significant alteration of stromal collagenous matrix (Kao and Liu, 2003). 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Simplified schematic of the repeating units in KS. Linear polymer of N-
acetylglucosamine and galactose. Adapted from Esko et al, 2009. 
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1.4.3.2 Chondroitin Sulphate/Dermatan Sulphate 
 
CS is composed of alternating N-acetylgalactosamine and glucuronic acid whilst DS 
is distinguished by the presence of iduronic acid in place of glucuronic acid (Figure 
1.7). Electron microscopy on bovine corneas revealed CS/DS proteoglycan filaments 
are 70 nm long (Scott, 1992) and attach to the protein core via a serine residue. 
Decorin, the other main proteoglycan present in cornea (Li et al, 1992), has a GAG 
chain composed of a CS/DS hybrid linked to serine residues in the core protein. 
Mutations in decorin have been linked to congenital stromal dystrophy, a disease 
characterised by corneal opacity demonstrating its importance within this tissue 
(Bredrup et al, 2005). Decorin is responsible for collagen organisation within the 
stroma (Scott, 1992) as well as influencing the activity of growth factors including 
transforming growth factor β (Iozzo et al, 1999).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4.4 Collagen-Proteoglycan Interactions 
 
Evidence suggests that there is direct contact between collagen fibrils and the 
proteoglycan protein core. Two-dimensional electron microscopy used to measure 
Cuprolinic blue-stained tissue has shown that CS/DS proteoglycans are 70 nm long, 
whereas KS proteoglycans are 40 nm long (Scott, 1992). Various models have been 
proposed for the collagen organisation within the stroma. Farrell and Hart considered 
models where GAG chains formed bridges between collagen fibrils. For example, six 
GAG chains from one collagen fibril would connect six neighbouring fibrils (Farrell 
Figure 1.7 Simplified versions of CS and DS. Repeating units of N-acetylgalactosamine and 
glucuronic acid are present in CS whereas glucuronic acid is substituted for iduronic acid in DS. 
Modified from Esko et al, 2009. 
 
CS 
DS 
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and Hart, 1969). All of the models have one thing in common, that being, they all 
have a sixfold symmetry of the collagen-proteoglycan interaction. Muller offered a 
theory similar to Farrell’s which included six proteoglycan bridges extending from 
one collagen fibril. In this model the bridges do not interact with the nearest or 
adjacent collagen fibril but with the next nearest neighbouring fibril (Muller et al, 
2004). This would result in a sixfold symmetry. Nevertheless, transverse views of the 
stroma show it does not have a perfect sixfold symmetry and that this is not a 
requirement for transparency. A more recent study proposed a model whereby 
proteoglycan protein cores attach to the collagen fibril leaving their GAG chains to 
interact with other GAG chains. No sixfold arrangement was observed in this three 
dimensional tomography study but it did show bridges connecting fibrils (Lewis et al, 
2010). The three-dimensional reconstructions using bovine cornea found that CS/DS 
proteoglycans form long chains that extend between several collagen fibrils whereas 
KS proteoglycans, being shorter, connect only adjacent fibrils. In the model proposed 
by Lewis, the GAG chains, if long enough, can make noncovalent antiparallel 
connections between the same proteoglycan, or a mix (i.e. KS and CS/DS chain). This 
study also describes how opposite forces are present between collagen fibrils, an 
attractive and repulsive force. The attractive force is produced by the thermal motion 
between the GAG chains arising between the fibrils due to the chain vibrations that 
pull the core proteins together. The repulsive force is caused by the Donnan potential, 
positively charged ions are drawn in by the charges on the GAG chains creating a 
local gradient within the stroma that attracts water molecules by osmosis (Elliott and 
Hodson, 1998). The water molecules occupy the space between the fibrils causing a 
repulsive force between them. It is thought that these two forces are equal, hence, the 
space between the collagen fibrils is maintained (Lewis et al, 2010) (Figure 1.8).  
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1.5 Transparency Theories  
 
Several transparency theories exist within the literature but there is still debate about 
which one represents best the cornea itself. A lattice or interference model suggesting 
that the cornea is made of a hexagonal lattice of regularly arranged collagen fibrils 
with equal spacing was proposed by Maurice (1957). Maurice recognised a regular 
hexagonal lattice would result in secondary radiation emanating from the fibrils to 
interfere either constructively or destructively. If the size of the components within 
this lattice is less than that of the wavelength of the incoming light, crests would sum 
to troughs in every direction except forward. In simpler terms, all of the secondary 
light would be cancelled out except for that moving in the forward direction resulting 
in transparency (Maurice, 1957).  
 
Figure 1.8 Proposed models for proteoglycan controlling mechanisms and collagen-proteoglycan 
interactions. Two opposite forces exist between collagen fibrils, an attractive force caused by the 
thermal motion of the proteoglycan/GAG complex (A) and a repulsive force due to the Donnan effect 
(B). (C) Black arrows indicate the antiparallel interactions between CS/DS GAG chains, whereas the 
black arrowheads represent the interaction between KS GAG chains. White arrowhead shows the 
hybrid KS-CS/DS antiparallel interaction. Taken from Lewis et al, 2010. 
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EM studies do not show a regular packing of collagen and some believe that a less 
ordered structure would also allow transparency (Hart and Farrell, 1969; Cox et al, 
1970). It is thought that the narrow distance between adjacent fibrils is of more 
importance i.e. this distance must be similar and less than half the wavelength of the 
incoming light. As long as the degree of order is sufficient to warrant constructive 
interference of waves only in the forward direction and destruction of scattered light, 
corneal transparency will prevail (Hart and Farrell, 1969). Proteoglycans are also 
thought to be implicated in the onset of corneal transparency during development. 
Variations in the nature of the proteoglycans are thought to be important in the 
regulation of cell migration and differentiation during corneal development (Quantock 
and Young, 2008).  
 
1.6 Descemet’s Membrane 
 
Descemet’s membrane, the basal lamina of the endothelium, is predominately 
composed of type IV (Kefalides et al, 1976) and type VIII collagen (Tamura et al, 
1991). This membrane was first described by Descemet in 1758, a membrane 
produced by the endothelium (Hay and Revel, 1969; Perlman and Baum, 1974) with a 
more detailed structure than most. In adults the membrane is divided into two zones, 
anterior and posterior. The anterior third of Descemet’s is approximately 3.5µm thick, 
produced during development and viewed as an irregular banded pattern. The 
remaining two thirds of the membrane is the posterior non-banded zone. This zone 
increases with age, reaching up to 20µm in some elderly patients (Murphy et al, 
1984). Descemet’s membrane is attached to the endothelium by a transitional zone 
known as the ‘interfacial matrix’, an area where type IV collagen is observed (Fitch et 
al, 1990). Fibronectin and laminin (Gordon, 1988) are also present within the 
membrane. Fibronectin adheres the endothelial cells to the membrane 
(Gospodarowicz et al, 1979), however, its exact location is yet to be determined. 
Some studies report its presence on the stromal side of the membrane (Tervo et al, 
1986; Sramek et al, 1987) or in a bilayered distribution (Morton et al, 1989). 
 
1.7 The Corneal Endothelium 
 
The posterior surface of the cornea is lined by a single layer of hexagonal cells known 
as the endothelium. Hay and Revel (1969) concluded this layer was derived from a 
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mesodermal origin in the avian cornea. Johnston’s findings contradicted these 
conclusions suggesting that corneal endothelial cells are derived from 
neuroectodermal origin rather than mesodermal as originally thought (Johnston et al, 
1979). Mitosis occurs in young human endothelium, but is infrequent in the adult 
(Joyce et al, 1996), with an average cell density of 2000cells/mm
2
. The corneal 
endothelium measures 4-6µm thick. The number of endothelial cells declines through 
life, however, the number of cells present at birth is enough to last a lifetime (over 
100 years). The minimum density required to maintain the functions of the cell 
monolayer is 400-700cells/mm
2
 (Bourne and Kaufman, 1976). Cell-cell contact 
prevents cell proliferation (Wulle and Lerche, 1969), a process known as contact 
inhibition. The benefit of a non-proliferating endothelial layer is unclear. Typically 
active endothelial cells are identified as having large nuclei, numerous mitochondria, 
prominent endoplasmic reticulum and Golgi apparatus. A healthy endothelial layer 
has cells of uniform size with between 70-80% of cells having a hexagonal shape.  
 
In chicks interdigitations are present on the lateral and basal membranes of the 
corneal endothelium during development (Figure 1.9) but decrease by 13 days post 
hatch as the cells have spread, this could act as a mechanism for reserving the cell 
membrane (Materson et al, 1977).  
 
 
 
 
 
 
 
 
 
 
 
Endothelial wound healing occurs by enlargement and migration of remaining cells 
resulting in an age related cell size increase (Figure 1.10) (Svedbergh and Bill, 1972; 
Laing et al, 1976; Murphy et al, 1984; Landshman et al, 1988). Cells surrounding the 
wound enlarge and elongate into the damaged area without losing contact with 
Figure 1.9 Interdigitations present in the endothelial cell membrane at stage 36. Interdigitations 
(arrowheads) are thought to act as a reserve/store of the cell membrane (Materson et al, 1977).  
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neighbouring cells. This mechanism is known as monolayer spreading (Kaufman and 
Katz, 1977; Joyce et al, 1990). 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.7.1 Proliferation  
 
Studies have found a higher cell density of cells in the periphery compared to the 
centre of the endothelial layer in normal human corneas (Schimmelpfennig, 1984). 
The peripheral regions also have a reduced rate of cell density reduction suggesting 
that this could be a regenerative zone. Telomerase activity was found in peripheral 
regions in both young and old donors, with younger donors having increased 
telomerase activity compared to the older group. However, the same study found no 
telomerase activity in central cornea (Whikehart et al, 2002). These findings suggest 
that the peripheral regions of the endothelium may act as a source of cell renewal. 
Endothelial cells are capable of cell proliferation but remain arrested in the G1-phase 
of the cell cycle, a theory supported by Joyce, who found no Ki67 expression (a 
marker of actively cycling cells) (Joyce et al, 1996). Studies comparing old and young 
endothelium showed significantly lower numbers of older donor endothelial cells 
entering the cell cycle compared to younger cells (Senoo and Joyce, 2000). This 
signifies that age related changes exist within endothelial cells, decreasing their 
proliferative capacity.  There is also strong evidence that cell-cell contact is an anti-
proliferative factor and a predominant cause of total cessation of endothelial 
proliferation in vivo (Senoo et al, 2000).  
Figure 1.10 Age related changes in endothelium cells. (A)20 years (B)44 years (C)59 years (D)69 
years (E)83 years. Decreased cell density and increased cell size are observed (Laing et al, 1976). 
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1.7.2 Growth Factors 
 
Growth factors act by binding to cell-surface receptors, resulting in a range of 
intracellular signals that are important for a variety of cellular processes. Many of the 
growth factors are produced by the endothelial cells themselves or are present in the 
aqueous humor and help to regulate the monolayer. Growth factors may be beneficial 
not only for endothelial proliferation in wound healing but also as a component of 
corneal preservation media for human donor corneas. A proliferative additive in 
preservation medium may result in less endothelial cell loss and improved graft 
results.  
 
Epidermal growth factor (EGF) has many biological activities throughout the body 
including cell growth and proliferation via the EGF receptor. In the corneal 
endothelium EGF stimulates cell division, migration and elongation of cells in cell 
culture systems in bovine (Gospodarowicz et al, 1977; Crow et al, 1994), human 
(Fabricant et al, 1982; Samples et al, 1991) and rabbit models (Raymond et al, 1986; 
Hongo et al, 1992). Interestingly, in one study, EGF increased cell cycle entry in older 
cells with relatively little effect on younger cells (Senoo and Joyce, 2000) which may 
be beneficial in endothelium regeneration in elderly patients. Platelet derived growth 
factor (PDGF) promotes wound healing in human (Hoppenreijs et al, 1994) and also 
stimulates mitosis of endothelial cells in bovine and rabbit (Hoppenreijs et al, 1993; 
Hecquet et al, 1990). Fibroblast growth factor (FGF) changes corneal endothelial cell 
shape and stimulates mitosis in bovine (Feldman et al, 1992, Woost et al, 1992), 
rabbit (Raymond et al, 1986; Kay et al, 1993) and human (Engelmann et al, 1988; 
Nayak and Binder, 1984). There is still much work to do in this area of endothelial 
regeneration, for example the effect of these agents on older endothelial cells and the 
side effects. However, they could be beneficial in endothelial wound healing and 
repair. There are also features that negatively regulate proliferation such as 
transforming growth factor-2 (TGF-2) present in the aqueous humor. Contact 
inhibition can also stop endothelial cell proliferation, leaving the monolayer in a 
contact-inhibited state (Joyce et al, 2002). Other external factors reducing cell counts 
include trauma, ultraviolet radiation, intraocular surgery, dystrophies and contact lens 
wear.  
Chapter 1: Introduction  
30 
 
1.7.3 Tight Junctions  
 
Tight junctions (maculae occludens) are located on the apical surface of the 
basolateral membrane (Hirsch et al, 1977; Stiemke et al, 1991). Trans-membrane 
molecules in tight junctions include occludins, claudins, and junction adhesion 
molecules (JAMs) that interact with their homophilic counterparts on neighbouring 
endothelial cells (Mehta and Malik, 2006) (Figure 1.11). Tight junctions in the 
endothelial layer offer a weak resistance to the paracellular movement of water and 
solutes, this is apparent by the low trans-endothelial resistance of between 15-25Ω.cm 
(Edelhauser, 2006; Srinivas et al, 2004). However, if this barrier breaks down, stromal 
swelling will result (Edelhauser, 2006), demonstrating the importance of tight 
junctions in the maintenance of stromal hydration. TEM has shown electron dense 
regions between rabbit endothelial cells very early in gestation (Hirsch et al, 1976), 
these were interpreted as tight junctions. A more complicated junctional network is 
built as more strands are formed and a more complex tight junction results in 
decreased endothelial permeability (Stiemke et al, 1991). This was tested using 
carboxyfluorescein, a hydrophobic dye measuring intracellular permeability (Grimes 
et al, 1982). Peroxidase injection fills intercellular spaces either side of the junctions 
which suggests incomplete zona occludens exist in the endothelial layer (Kaye et al, 
1973; Hirsch et al, 1976). Tight junctions could also influence the endothelial pump 
by helping maintain the osmotic gradient that promotes trans-endothelial fluid 
movement and assisting apical-basal polarity of proteins including those transported 
via the pump. If tight junction breakdown occurs polarity and pump rate would 
become affected.  
 
 
 
 
 
 
 
 
 
 
Figure 1.11 Apical junctions present in the endothelial monolayer. Schematic of the apical junction 
complex. Tight junctions are made up of several trans-membrane and cytoplasmic components 
including occludin, claudin, and JAM that maintain homophilic interactions with their counterparts in 
the neighbouring cells. They are also linked to the actin cytoskeleton via adapter proteins such as ZO-1 
(Adapted from Srinivas 2010). 
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Gap junctions are also present in the endothelial layer although they diminish in 
number with age, suggesting they are present for increased intercellular 
communication when the endothelium is organising itself (Stiemke et al, 1991). One 
study found no change in endothelial permeability despite the loss of gap junctions 
which reveals these junctions may not be of primary importance in the maintenance of 
the corneal endothelial barrier (Watsky et al, 1990).    
 
1.7.4 Membrane Potential 
 
The resting membrane potential of any cell is the result of ionic conductance 
properties that arise from transporters and channels present in the cell membrane. The 
resting membrane potential will have an important role in the cells transport 
functions. Different studies have been carried out aiming to measure resting 
membrane potentials of the corneal endothelium, potentials ranged from +2.2(1.0) to 
-61.6(4) mV. Most studies found mean values ranging between -30 to -50mV, 
measured between 22 and 37C in intact and cultured cells (Wiederholt and Koch, 
1978; Jumblatt, 1981; Jentsch et al, 1984).  
 
1.7.5 Pump 
 
The epithelium and endothelium are important layers in the cornea which were first 
recognised to behave as semi-permeable membranes by Kinsey and Cogan (1942). 
The endothelial layer has as a leaky membrane (Hirsch et al, 1977) due to the low 
resistance junctions between the cells, this enables a leak of solutes and fluid across 
the endothelial barrier into the stroma. The layer’s primary role in corneal hydration is 
maintained by a pump function; this has been demonstrated by a study measuring the 
corneal thickness in vitro with removal of the epithelium. The results show that 
corneal thickness was maintained for more than 6 hours casting doubt on the role of 
the epithelial layer in regulating corneal hydration (Doane and Dohlman, 1970). Riley 
concluded that the epithelium is a semi-permeable layer but acts primarily as a barrier 
and therefore the endothelium must control corneal hydration (Riley, 1971). 
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1.7.5.1 Sodium Bicarbonate Cotransporter  
 
Ion-coupled fluid transport is important for corneal hydration and transparency. 
Studies have shown that hydration and intracellular pH (Bonanno and Giasson, 1992; 
Bonanno et al, 1999) are dependent on the transport of bicarbonate and are sensitive 
to carbonic anhydrase inhibitors (Fischbarg and Lim, 1974; Hodson, 1971; Hodson, 
1974: Hodson and Miller, 1976: Kuang et al, 1990). Bicarbonate
 
is now recognised to 
be one of the important ions involved in the endothelial pump system (Hodson and 
Miller, 1976; Jentsch et al, 1984; Riley et al, 1995; Bonanno, 2003) and results in a 
small apical side negative transepithelial potential (Fischbarg and Lim, 1974; Hodson 
and Miller, 1976). Two thirds of the substrate is derived from exogenous bicarbonate, 
the remaining third is supplied by the conversion of exogenous carbon dioxide by 
intracellular carbonic anhydrase (Hodson and Miller, 1976). 
 
Evidence suggests that an electrogenic bicarbonate sodium cotransporter exists and is 
responsible for mediating bicarbonate
 
exit via the endothelial apical membrane 
(Jentsch et al, 1985). Further studies carried out on bovine tissue have shown there is 
an uptake of bicarbonate
 
by a sodium (Na
+
)
 
dependent, 4,4'-Diisothiocyano-2,2'-
stilbenedisulfonic acid sensitive electrogenic transporter (Bonanno and Giasson, 
1992; Bonanno et al, 1999; Jenstch et al, 1984). Rationale behind this cotransporter 
participating in bicarbonate uptake was indicated by three findings 1) steady-state pH 
was higher in the presence of bicarbonate 2) 4,4'-Diisothiocyano-2,2'-
stilbenedisulfonic acid added to the basolateral membrane reduced pHi and 3) 
intracellular Na
+
 concentration was higher in the presence of bicarbonate ions 
(Bonanno and Giasson, 1992).  
 
As well as the basolateral Na
+
/2HCO3
-
 cotransporter (NBC) (Bonanno and Giasson, 
1992; Bonanno et al, 1999; Sun & Bonanno, 2003) the endothelial transport system 
requires the presence of the Na
+
/K
+
/2Cl
-
 cotransporter, the 2Cl
-
/2HCO3
-
 exchanger, 
Na
+
/H
+
 exchange and apical anion channels permeable to both chloride (Cl
-
) and 
bicarbonate. It is thought that together these channels and transporters move 
bicarbonate
 
from the stroma into the aqueous humor. There is now a consensus that 
the NBC is present on the basolateral membrane. Movement of bicarbonate
 
requires 
energy (Green, 1991; Hodson and Miller, 1976) provided by the Na
+
/K
+
 ATPase 
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located on the basolateral membrane (Green, 1991; Hodson and Hodson, 1988). The 
location of the Na
+
/K
+
 ATPase on the basolateral membrane suggests that the 
cotransporter is probably located here to obtain the energy necessary for bicarbonate
 
transport (Wigham et al, 1994). Studies have also localised the cotransporter to the 
basolateral cell membrane in bovine corneal endothelium (Sun et al, 2000). 
Basolateral NBC loads endothelial cells with bicarbonate from the stromal side, once 
inside the cell there is a net conversion of bicarbonate to carbon dioxide by carbonic 
anhydrase II. There are three possible modes of bicarbonate efflux into the aqueous 
humor, 1) Cl
-
/HCO3
- 
 exchange, 2) CO2 efflux and conversion to bicarbonate
 
 via 
membrane bound carbonic anhydrase IV (Bonanno et al, 1999) and finally 3) 
conductive flux through anion channels (Sun et al, 2000). A 1:2 stoichiometry results 
in an influx of bicarbonate
 
ions, thus, this is thought to exist in endothelial cells 
(Bonanno and Giasson, 1992). Two isoforms of NBC have been cloned, kidney 
(kNBC) and pancreatic (pNBC), the difference between the two lies in the NH2 
terminus. The stoichiometry of both kNBC and pNBC can change depending on the 
cell type (Gross et al, 2001) and location, respectively. The pancreatic isoform is 
present in bovine (Sun et al, 2000) and human (Sun and Bonanno, 2003) corneal 
endothelial cells. One study suggests that both the kNBC and pNBC isoforms are 
present in cultured and fresh human corneal endothelial cells (Usui et al, 1999), 
however, a later study contradicted these findings detecting only pNBC in fresh 
human corneal endothelial cells (Sun and Bonanno, 2003). Studies have found that 
apical permeability to bicarbonate
 
is significantly lower than the basolateral 
permeability (Bonanno et al, 1999), consequently this could be the rate-limiting step 
in the transendothelial transport of bicarbonate. 
 
1.7.5.2 Na
+
/H
+
 Exchange 
 
There is also evidence for sodium hydrogen (Na
+
/H
+
) exchange in endothelial cells. 
When an acid load is counteracted to recover the pHi in the absence of bicarbonate 
ions, the Na
+
H
+
 exchanger becomes inhibited by amiloride (a Na
+
/H
+
 exchanger 
inhibitor) (Bonanno and Giasson, 1999). The predominant alkalinising mechanism, 
Na
+
/H
+
 exchange, is thought to be present but not active in the presence of 
bicarbonate. Previous studies on the Na
+
/H
+
 exchanger show that the activity is 
reduced as pHi increases and activated when pH decreases (Aronson, 1985). This 
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occurs in all cell types including the corneal endothelium suggesting pH sensitivity 
with activity ceasing at pH 7.2-7.3). The exchange becomes active when intracellular 
pH is reduced leading to alkalinisation of endothelial cells which is the equivalent of 
introducing bicarbonate ions. However, this transport mechanism acts purely as a 
housekeeping mechanism in response to pH challenges.  
 
1.7.5.3 Cl
-
/HCO3
-
 Exchange 
 
Bonanno et al found expression of an anion exchanger (AE)2 in fresh bovine corneal 
endothelial cells present on the lateral membranes (Bonanno et al, 1998). The 
exchange is responsible for Cl
-
 influx and bicarbonate efflux which is thought to 
modulate intracellular bicarbonate or load endothelial cells with Cl
-
. When Cl
-
 is 
removed from ringers solution, pHi increases (Bonanno and Giasson, 1992), this 
alkalisation is inhibited by 4,4'-Diisothiocyano-2,2'-stilbenedisulfonic acid. When Cl
-
 
is present with bicarbonate, its influx and efflux is slowed by 4,4'-Diisothiocyano-
2,2'-stilbenedisulfonic acid suggesting the presence of a Cl
-
/HCO3
-
 exchange. When 
Cl
-
 is removed/replaced from solution the membrane significantly depolarises, 
thought to result in bicarbonate influx through the NBC.  
 
1.7.6 pH 
 
Bicarbonate and Na
+
 movement are both influenced by the pH of the bathing solution 
(Fischbarg and Lim, 1974) and the intracellular level of bicarbonate is related to the 
intracellular pH. It is thought the main regulators of intracellular pH are the Na
+
/H
+
 
exchanger, NBC and Cl
-
/HCO3
-
 exchange. The movement of CO2 into cells causes a 
small acidification followed by a slower, larger alkalinisation due to bicarbonate 
influx via the NBC cotransporter. A peak pHi is reached which is followed by a small, 
slow acidification to restore steady state pH. This drop in pHi may be due to 
bicarbonate efflux from the cell. The removal of bicarbonate/CO2 from the cell 
reverses the pHi changes. When no bicarbonate is present in solution, Na
+
 is required 
to recover the cells from acid load and maintain its steady state pH via a Na
+
 
dependent proton efflux in a bicarbonate free environment.  
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1.7.7 Corneal Development 
 
1.7.7.1 Primate Cornea 
 
The optic cup and lens placode have formed by the fifth week of development. The 
cornea begins its development when the lens detaches from the overlying ectoderm. 
Prior to endothelial development on embryonic day 40 (E40), a narrow corneal stroma 
containing disorganised fibrils is present between the corneal epithelium and the lens 
at E38 (Ewer, 1970). Two waves of mesenchymal cells form the corneal endothelium 
and corneal keratocytes (Dublin, 1970; Ewer, 1970). Corneal swelling precedes 
invasion of the second mesenchymal cells in primate (Ozanics et al, 1977) which are 
destined to become the corneal fibroblasts. Descemet’s and Bowmans membrane are 
formed between the third and eighth month.                                                                                                                                                                                                                                                                                                      
 
1.7.7.2 Avian Corneal Development 
 
Development of the avian eye begins with the appearance of the optic vesicle which 
induces lens placode development. Extracellular matrix is first observed at E3 as a 
1µm layer of collagen fibrils, termed the ‘primary stroma’, which triples in thickness 
between E3 and E3.5 (Hay and Revel, 1969). The presumptive epithelium is two cells 
thick at E3. Meanwhile, mesenchymal cells present at the lip of the optic cup at E3.5 
are destined to become the corneal endothelium (Hay and Revel, 1969). These cells 
flatten in preparation for their migration along the posterior face of the cornea at E4, 
covering the entire posterior surface in 1.5 days. By E5 the primary stroma is 10µm 
thick, composed of at least 20 layers, it then doubles in thickness by E5.5 to between 
30µm and 50µm. This event simultaneously occurs with a second invasion of 
mesenchymal cells destined to become the corneal keratocytes on E6; cells 
responsible for producing the secondary stroma. Keratocan mRNA is expressed by all 
keratocytes as soon as they migrate into the stroma on E6 (Conrad and Conrad, 2003). 
Hyaluronate reaches its highest point at stage 27/28 (Toole and Trelstad, 1971), a 
GAG that is thought to be important in early developmental events because of its 
appearance in multiple embryonic tissues. Some studies have shown increased levels 
of hyaluronate during mesenchymal cell migration suggesting it influences 
mesenchymal cell behaviour (Toole and Gross, 1971). By E6 the endothelium has 
begun to produce a basement membrane that thickens to form Descemet’s membrane. 
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KS proteoglycans are then synthesised between E5-E7 (Hart, 1976; Funderburgh et al, 
1986) becoming highly sulphated by E14 (Hart, 1976), whilst the lumican core 
protein increases three-fold between E7 and E9 (Cornuet, et al, 1994). The 
accumulation of KS proteoglycans between the E12-E18 developmental period may 
influence matrix hydration and collagen fibril spacing (Liles et al, 2010). Keratocan 
mRNA steadily declines from E9-E18 whilst lumican levels remain high (Dunlevy et 
al, 2000). Hyaluronate is removed by hyaluronidase between E9-12 resulting in 
decreased water binding affinity in the stroma. The secondary stroma undergoes 
structural modifications from E9 through to hatching at E21; these include stromal 
compaction (Hay and Revel, 1969; Quantock et al, 1998; Siegler and Quantock, 2002) 
and proteoglycan alterations, previously mentioned (Anseth, 1961; Toole and 
Trelstad, 1971). The cornea reaches its maximum thickness of 220µm at E9 soon after 
the mesenchymal cell invasion is complete on E10 (Hay and Revel, 1969), probably 
as a result of secreted type I/V collagen fibrils (Linsenmeyer et al, 1984; Birk et al, 
1986) and stromal oedema. Descemet’s membrane is complete by E12 whilst 
hyaluronidase activity decreases. Rapid removal of water from the cornea occurs due 
to decreased water binding affinity and an increased pumping mechanism within the 
endothelium, dehydrating and thinning the stroma. The secondary stroma becomes 
complete at this stage with a thickness of approximately 200µm, invaded throughout 
by mesenchymal cells (Hay and Revel, 1969). Light transmission increases from 40% 
at E14 to 96% by E19 (Coulombre and Coulombre, 1958) due to the increase in 
collagen fibril packing (Quantock et al, 1998) and reorganisation of the collagen. 
 
1.7.7.3 Endothelial Development 
 
Endothelial cells are derived from mesenchyme and associated with the vascular 
uveal tract. The mesenchyme destined to form the endothelium is present on E2 in the 
avian cornea before moving towards the lip of the optic cup where it stalls for a day. 
At E4 the cells migrate into place, pushing their way through the subectodermal 
stroma that has begun to swell by this point (Coulombre and Coulombre, 1958). The 
cells and stroma are pushed away from the lens by the fibrous matrix that fills the now 
anterior chamber (Bard et al, 1975). Endothelial cells are capable of moving by 
extending cell processes forward at a rate of approximately 1µm/minute (Bard et al, 
1975). A confluent sheet is formed by E6; subsequently, junctions occur between the 
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cells whilst cilia extend into the anterior chamber (Hay and Revel, 1969). Soon after 
the formation of the endothelium, hyaluronic acid is produced by the cornea, some 
studies suggesting it is produced by the endothelial layer itself (Treslstad et al. 1974). 
Corneal hydration increases on E6, probably as a result of the cells leaky quality, a 
feature that will eventually be counteracted by its pumping mechanism. Descemet’s 
membrane appears as a narrow band of extracellular matrix, produced by the 
endothelium.  
1.7.8 Endothelial Dysfunction  
 
Posterior corneal dystrophies are characterised by abnormalities in the endothelium 
and Descemet’s membrane. Defects in the endothelial layer can result in an 
oedematous stroma due to a defective or decreased fluid transport mechanism. The 
primary corneal endotheliopathies are presented in the table below (Table 1.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.7.8.1 Fuchs’ Endothelial Corneal Dystrophy 
 
Ernst Fuchs, an Austrian Ophthalmologist, is best known for his work on dystrophia 
epithelialis corneae (Fuchs’, 1910). This is now more commonly known as Fuchs’ 
endothelial corneal dystrophy (FECD), the most common indication for corneal 
transplantation (Adamis et al, 1993). FECD is a bilateral disease leading to corneal 
clouding as a result of dysfunctional endothelial cells. There are two forms of FECD, 
a rare early-onset form (Biswas et al, 2001) and the more common late-onset form 
Table 1.1 Primary corneal endotheliopathies. Disorders affecting the corneal endothelium and the 
features they display. 
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which affects approximately 4% of the population. Early-onset FECD results in 
endothelial decompensation in the third or fourth decade of life whilst the late-onset 
form develops into advanced stages by the sixth to ninth decade of life. A major 
hallmark of the disease are the endothelial excrescences or guttae that appear as 
indentations or drops on the posterior surface of Descemet’s membrane (Figure 1.12). 
Guttae eventually become confluent, starting centrally before spreading peripherally 
so that the endothelium attains a beaten metal appearance. The guttae are 
accumulations of collagen posterior to Descemet’s membrane. When the central 
guttae lead to corneal hydration, FECD can be identified as the cause. 
 
 
 
 
 
  
 
 
 
 
Descemet’s membrane is also significantly thickened in FECD (Wilson and Bourne, 
1988), this thickening occurs in the posterior nonbanded zone (Iwamoto and DeVoe, 
1971). FECD can be broken down into three stages. Stage I is characteristically 
asymptomatic with thickened Descemet’s membrane and corneal guttae which appear 
as small, centrally located black dots on the endothelium under specular reflection. 
Endothelial cell loss occurs at this early stage but is compensated for by cell spreading 
and polymegethism; as a result there is a lack of symptoms. The disease progresses 
causing a slight loss of sight due to stromal oedema, a feature establishing the patient 
as stage II. Stromal oedema creates a ground-glass area studded with water clefts 
whilst corneal thickness increases twofold. Large lakes of fluid appear within and 
under the epithelium which can burst leaving epithelial defects. Stage III is diagnosed 
by bullae that occasionally rupture causing intense pain alongside subepithelial and 
stromal scar tissue, this leads to vascularisation of the cornea and decreased 
transparency (Table 1.2).  
 
Figure 1.12 Features of FECD dystrophy in patients. Scanning electron micrograph of guttae 
present on the corneal endothelium (Klintworth, 2009). 
A 
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For treatment, hypertonic agents such as 5% NaCl are used to raise the 
hyperosmolarity of the tear film as well as a warm hair dryer to aid corneal 
dehydration. In the final stage of the disease, a loose fitting soft contact lens can help 
decrease irritation and some of the pain caused by the epithelial bullae. Intraocular 
pressure, thought to be linked to stromal oedema, can be reduced to help control 
swelling. A final measure, usually required for those patients in stage III, is surgical 
intervention in the form of penetrating keratoplasty. 
 
Disease pathogenesis is not yet fully understood in FECD, however, recent studies 
have linked mutations in collagen VIII as a possible cause in the early-onset form of 
the disease (Biswas et al, 2001; Gottsch et al, 2005; Jun et al, 2012). Further 
investigation into the pathogenesis of the disease will help determine its cause and in 
defining appropriate treatments which are currently lacking in FECD.  
 
1.7.8.2 Additional Corneal Endotheliopathies  
 
Posterior polymorphous corneal dystrophy is an autosomal dominant corneal 
dystrophy with a range of clinical features including endothelial vesicles (Waring et 
al, 1978; Krachmer, 1985). The endothelial cells appear epithelial like including 
multiple layers and can extend over the iris and trabecular meshwork. Some studies 
Table 1.2 Documented stages of FECD dystrophy. Three separate stages of the disease are 
recognised by the advancing clinical features. 
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suggest that the normally non-mitotic cells of the endothelium do divide in this 
disorder, taking on epithelial like properties (Blair et al, 1992). 
 
Congenital hereditary endothelial dystrophy is a rare disorder characterised by 
bilateral corneal oedema occurring soon after birth. Patients have thickened 
Descemet’s membrane (Chan et al, 1982) and deteriorated corneal endothelium 
(Ehlers et al, 1998), which is likely to cause stromal swelling.  
 
Iridocorneal endothelial dystrophy comprises of Chandler’s syndrome, essential iris 
atrophy and iris nevus syndrome. The features of these dystrophies include corneal 
oedema, glaucoma and iris changes (Chandler, 1955).  
1.7.9 Corneal Surgery 
 
The predominant treatment for corneal endothelial dysfunction, until recently, was 
penetrating keratoplasty (PK), a surgical intervention replacing the entire cornea 
(Figure 1.13). PK has come to be very popular and successful in most patients 
suffering from corneal dystrophies and trauma, however, this surgery does carry risks 
including prolonged visual recovery, induced astigmatism and globe fragility.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Replacement of only the damaged layers of the cornea is now becoming a more 
popular choice for surgeons and patients. Deep anterior lamellar keratoplasty (DALK) 
removes the diseased/damaged anterior layers preserving the healthy posterior 
Figure 1.13 Total number of keratoplasties carried out from 1999 to 2009 under the Corneal 
Transplant Service (UK). All keratoplasties (Total), Deep anterior lamellar keratoplasty (DALK), 
Endothelial Keratoplasty (EK) in the 1999/2000 till 2008/2009 period. (Keenan et al, 2010). 
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Descemet’s membrane whilst posterior lamellar keratoplasty (PLK) removes the 
damaged/diseased posterior stroma and Descemet’s membrane preserving the healthy 
anterior layers. During PLK recipient stroma is dissected at 80-90% of its depth along 
with Descemet’s membrane and endothelium before replacement with donor stroma, 
Descemet’s membrane and endothelium (approximately 10-20% of corneal 
thickness). The procedure results in faster recovery, reduced astigmatism, fewer 
sutures, whilst also maintaining globe integrity. This overcomes some of those 
problems associated with PK (Melles et al, 2000, Gorovoy, 2006, Price & Price, 
2007). A 9.0mm scleral incision is created before donor insertion (Melles et al, 1998, 
1999; Terry and Ousley, 2003), a practice that was further modified by decreasing the 
incision to 5.0mm, combined with donor tissue folding prior to insertion (Melles et al, 
2002). PLK was later referred to as deep lamellar endothelial keratoplasty (DLEK), a 
technique using the same procedure with modified instruments (Terry and Ousley, 
2003).  
 
 
1.7.9.1 DSEK 
 
DLEK was advanced further by removing Descemet’s membrane from the host 
cornea without the posterior stroma, a procedure termed descemetorhexis (Melles et 
al, 2004). The donor tissue, consisting of posterior stroma, endothelium and 
Descemet’s membrane, is transplanted onto the recipient posterior surface. This 
procedure was later named Descemet’s stripping endothelial keratoplasty (DSEK) 
(Price and Price, 2005). DSEK showed a lower rate of graft rejection (7.5%) 
compared to PK (13%) within the first 2 years of the surgery in a study by the 
Swedish Corneal Graft Registry for those patients suffering from FECD (Allan et al, 
2007). A microkeratome has allowed this technique to have a greater degree of 
precision and a smoother graft-host interface. The use of the microkeratome resulted 
in a procedure now known as Descemet’s stripping automated keratoplasty (DSAEK) 
(Gorovoy, 2006). This technique is now favoured by many corneal surgeons for 
correcting endothelial related problems.  
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1.7.9.2 Non Descemet’s Stripping Automated Endothelial Keratoplasty 
(nDSAEK)  
 
Non-Descemet’s stripping automated endothelial keratoplasty (nDSAEK) involves a 
similar method to DSAEK but instead leaves the host cornea fully intact (Price and 
Price, 2006; Kobayashi et al, 2008) (Figure 1.14). This method was introduced for the 
treatment of failed PKs (Price and Price, 2006) and endothelial dysfunction not 
associated with guttae. nDSAEK is not beneficial in FECD as the pathologic 
endothelial layer needs to be removed, a step not involved in nDSAEK (Kobayashi et 
al, 2008). In relevant circumstances, such as extensive endothelial cells loss and failed 
PK, Kobayashi has shown positive results for this surgery, with superior visual acuity 
and little induced astigmatism. It also diminishes the need to remove Descemet’s 
membrane resulting in a simpler procedure. As well as failed PK surgery and 
endothelial dysfunction not associated with FECD, nDSAEK may also be beneficial 
for aphakic aniridic eyes. DSEK/DSAEK can be challenging in an eye where both the 
iris and lens are missing as Descemet’s membrane stripping can lead to fragments of 
recipient Descemet’s membrane falling back onto the retina. nDSAEK, however, does 
carry complications, one of which includes graft dislocation after surgery (Kobayashi 
et al, 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14 Schematic of the corneal components post nDSAEK surgery. Host cornea remains 
fully intact anterior to donor stroma, donor Descemet’s membrane and endothelium. Taken from 
Masaki et al, 2012.  
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1.8 Summary and Objectives 
 
The structure and composition of the corneal stromal collagen is important and needs 
to be kept at a consistent hydration for corneal transparency to prevail. This, in part, is 
controlled by a pump mechanism present in the corneal endothelium, an essential 
monolayer of cells present on the posterior of the cornea. It is already known that the 
NBC plays an essential role in the endothelial pump, however, when this 
cotransporter is present in the developing cornea and if it correlates with stromal 
compaction and thinning is still unknown. The importance of this posterior layer is 
reiterated in corneal endotheliopathies whereby damaged or decreased endothelial 
cells results in stromal oedema and consequently, visual impairment. In circumstances 
where the endothelial cells are depleted or damaged beyond recovery, corneal surgery 
is the only remaining treatment at this time. Posterior corneal surgeries are becoming 
increasingly popular as they do not carry the same side effects as full PK. 
Pharmaceutical agents are now being brought to the market to maintain or increase 
endothelial cell survival. Both surgical and drug intervention have shown positive 
outcomes on visual acuity, however, the effects on the stroma and endothelial cells is 
unknown.  
 
The aims of this research were firstly to investigate the morphology of corneal 
endothelial cells and their expression of the NBC during avian embryonic 
development and secondly, to determine the effects of an early-onset FECD murine 
model on the posterior cornea. The final aim was to determine how the stroma and 
endothelium changes in response to DSAEK and nDSAEK surgery and after the 
addition of a Rho kinase (ROCK) inhibitor. 
 
Alterations in corneal thickness and protein expression in the endothelium, together 
with endothelial cell morphological changes will help us better understand the 
relationship between these factors. Determining the ultrastructural changes in the 
posterior stroma in disease models will help us realise the similarities to the human 
disease, and consequently, whether or not they are beneficial in defining the genetic 
changes and disease pathogenesis. Finally, observing corneal structure after surgery 
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and drug intervention will help clarify the positive and negative aspects of the 
individual treatments and the overall tissue alterations that occur. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 45 
 
 
 
 
 
Chapter 2: Materials and 
methods 
                                                                       Chapter 2: Materials and methods  
46 
 
2. 
 
This chapter outlines the experimental procedures used throughout the project, 
including tissue from developmental, diseased, surgical and pharmacologically 
targeted corneas.  
 
2.1 Experimental Models 
 
  2.1.1 Corneal Endothelial Development 
 
Fertilised White Leghorn chicken eggs (Henry Stewart, Lincolnshire, UK) were 
incubated at 37.5C in a humidified chamber (Brinsea products Ltd) for chicks aged 
between E8 and 18. All animals were killed in accordance with the Association for 
Research in Vision and Ophthalmology statement for use of animals for Ophthalmic 
and Vision Research and local ethical regulations. Embryonic chicks were used for 
general TEM, immunohistochemistry and A-sound ultrasonography for studies 
observing the corneal endothelium and corneal thickness in development. Corneas 
used for immunohistochemistry and TEM were excised by an incision around the 
limbus of the eye and immediately placed in either O.C.T. (optimal cutting 
temperature) or fixative solution, respectively.   
 
2.1.2 Pathology 
 
Knock-in mice were generated by Jun and colleagues (2012). Targeting vectors 
containing the Col8a2
Q455K/Q455K
 and Col8a2
L450W/L450W
 mutations were generated 
prior to incorporation into the mouse genome establishing an early-onset FECD 
murine model (see chapter 4 for more details). Following euthanasia by inhaled 
isoflurane followed by cervical dislocation, one eye of each animal was examined by 
clinical confocal microscopy using a Confoscan 3 microscope (Nidek, Fremont, CA). 
5-month-old mouse corneas with Col8a2
L450W/L450W
 or Col8a2
Q455K/Q455K
 homozygous 
knock-in gene mutations were stained with Cuprolinic blue to image sulphated 
proteoglycans before resin embedding and examination with TEM, alongside age-
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matched controls. Prior to processing tissue underwent digestion in specific 
glycosaminoglycan-degrading enzymes (see later). 
 
2.1.3 Surgery 
 
Posterior corneal surgery is becoming an increasingly popular alternative to PK 
because of the fewer complications that occur post-surgery. Japanese white rabbits 
that had undergone DSAEK and nDSAEK surgery were used to study the posterior 
ultrastructure of the cornea post-surgery. Surgeries were conducted by Dr. Hiroki 
Hatanaka (Kyoto Prefecture University of Medicine) and tissue was examined two 
weeks post-surgery.  
 
2.1.4 Non-Surgical Treatment 
 
ROCK inhibition is a novel treatment for endothelial disease revealing that it may 
prevent apoptosis and increase cell adhesion and proliferation in corneal endothelial 
cells. Studies have reported that the specific ROCK inhibitor, Y-27632, promotes 
adhesion and proliferation of monkey corneal endothelial cells, and decreases 
apoptosis (Okumura et al, 2009). Y-27632 has also been shown effective when 
applied topically in wound healing in vitro and in vivo (Okumura et al, 2012). These 
studies signify that ROCK inhibition with Y-27632 has the potential to regenerate the 
corneal endothelium where the number of cells is inadequate to maintain stromal 
deturgescence and in wound healing. ROCK-inhibitor-treated rabbit and human tissue 
obtained from Dr Naoki Okumura (Doshisha University, Kyoto) was prepared for 
conventional TEM to examine endothelial morphology. 
 
2.2 Experimental Protocols   
 
2.2.1 General Preparation for TEM 
 
Samples were fixed for 2-3 hours at 4°C in appropriate fixative in buffer solution 
(Table 2.1). Samples were trimmed and fixed in 1% osmium tetroxide (Sigma 
Aldrich, UK) in buffer (Table 2.1) for 1 hour before being contrasted in 0.5% aqueous 
uranyl acetate (Sigma Aldrich, UK) for 1 hour. Specimens were then dehydrated 
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through a graded ethanol series (70%, 90% and 100% [x2]) for 15 min each. 
Immersion into propylene oxide was conducted for 15 min before insertion into a 1:1 
propylene oxide: Araldite resin mixture for 1 hour prior to infiltration with fresh resin 
(see Appendix I). Embedding was carried out over 2 days with 3 changes per day. 
Tissue was embedded in moulds late on the second day and left to polymerise at 60°C 
for 72 hours.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.2 TEM Enzyme Treatment of Tissue 
 
Corneas undergoing proteoglycan localisation were prefixed in 4% paraformaldehyde 
in Tris acetate for 10 minutes prior to enzyme treatment. Original working stock for 
each enzyme was 5U, which was rehydrated in distilled water and added to Tris 
acetate buffer (Table 2.2).  
 
 
 
 
 
 
 
 
 
 
Table 2.2 Chondroitinase ABC and keratanase enzyme solutions. Enzymes were rehydrated in 
distilled water and Tris acetate buffer to obtain the above units. BSA-bovine serum albumin. See 
Appendix I for buffer components.  
 
Table 2.1 Buffer, Fixative and stains used in TEM studies. Glut-Glutaraldehyde, PF-
Paraformaldehyde, UA-Uranyl acetate and PTA-Phosphotungstic acid. See Appendix I for buffer 
components.  
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Corneas were rinsed in 1x Tris acetate buffer prior to incubation in the above enzyme 
solutions for 4 hours at 37°C with protease inhibitors to decrease protein degradation. 
Wild type and mutant corneas for the experiments investigating endothelial pathology 
each went through i) chondroitinase ABC digestion ii) keratanase digestion iii) buffer 
only treatment and iv) Cuprolinic blue only. Post enzyme treatment, corneas were 
rinsed in sodium acetate/0.1M magnesium chloride buffer prior to fixation overnight 
in 2.5% glutaraldehyde in 25mM sodium acetate buffer (pH 5.7) containing 0.1M 
MgCl2 and 0.05% Cuprolinic blue. Staining of GAGs was developed by Scott and 
Haigh (1985) using Cuprolinic blue. This stain allows observation of GAG chains on 
proteoglycan molecules helping determine how proteoglycans interact with collagen 
fibrils. After rinsing three times in sodium acetate buffer, samples were washed a 
further three times in 0.5% aqueous sodium tungstate (Sigma Aldrich, UK). Samples 
were dehydrated in 0.5% sodium tungstate in 50% ethanol for 15 minutes, before 
further dehydration in a graded ethanol series (70%, 90% and 100% [x2]) for 15 
minutes in each. Resin infiltration was carried out as discussed above. Blocks were 
stored at room temperature until required. Semi (0.5 µm) and ultra-thin (100 nm) 
sections were cut and collected on glass slides and uncoated copper grids, 
respectively, before being stained in appropriate solutions (Table 2.1). 
 
2.2.3 Staining 
 
Contrast observed in the electron microscope is produced by the differential scattering 
of electrons by the tissue embedded within the resin. Darker areas are due to the 
denser areas of the tissue, whereas the lighter areas correspond to those with less 
density. However, sometimes it is difficult to distinguish between different 
components of the tissue as well as between the resin and the tissue itself due to the 
section thickness. Thus, stains employing heavy metal salts are used to increase the 
contrast.  
 
A number of staining techniques are used in TEM which fall into two categories, 
positive staining and negative staining. Positive staining is visualised when the 
density of the biological structure is increased as opposed to the background. The 
heavy metal salts bind to parts of the tissue, increasing their density and subsequently, 
their contrast, whilst unbound stain is removed. Osmium tetroxide is used to increase 
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density; additional staining (post embedding with uranyl acetate and lead citrate) will 
increase the contrast further. The positive stains used in this thesis were uranyl acetate 
and lead citrate. Uranyl acetate, used before and after embedding, binds with 
phosphate and amino groups resulting in highly stained nucleic acids (Hayat, 2000). 
Lead ions are thought to bind to negatively charged components of the tissue, for 
example, those areas that have reacted with osmium and hydroxyl groups (Bozzola 
and Russell, 1999). In negative staining the macromolecule is unstained surrounded 
by a dark background, this type of staining has a minimal effect on the specimen 
itself. The substructure of the individual organelle is contrasted by stain penetration 
into the voids present within the specimen which is responsible for the dark 
background. Phosphotungstic acid is a commonly used negative stain, used alongside 
uranyl acetate. 
 
Additionally, Cuprolinic blue was also used in the experimental pathology 
experiments of FECD mouse models (Chapter 4). Cuprolinic blue was first introduced 
as a cationic RNA specific dye. Cuprolinic blue can be used to stain proteoglycans 
associated with collagen fibres and combined with enzymatic digestion can help 
determine the location of certain proteoglycans within the tissue (Scott, 1975). 
Cuprolinic blue was used in this study to determine if proteoglycans were altered in 
the FECD model and they’re placement in Descemet’s membrane.  
Grids were stained with either: 
i) Phosphotungstic acid (2%), and uranyl acetate-2min and 12 min respectively 
ii) Uranyl acetate (saturated) followed by lead citrate-12 min and 5min 
respectively. 
Grids were viewed using an electron microscope (JEOL 1010 transmission electron 
microscope with Gatan ORIUS SC100 CCD camera). 
 
For buffer and general TEM components see Appendix I. 
 
2.2.4 Electron Tomography 
 
Electron tomography is employed to obtain a three-dimensional image of a sample 
which has been tilted around a single axis. Each face of the ultra-thin corneal sections 
(120 nm) undergoing tomography was exposed to a colloidal gold solution (10 nm-
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BBl, Cardiff, UK). Thicker sections were used to help prevent tissue destruction, a 
problem that can occur due to the extensive amount of time the tissue is exposed to 
the electron beam. Colloidal gold was placed on both sides of the grid and served as a 
fiducial marker, facilitating alignment of the tilt micrographs. A −60° to +60° single 
axis tilt series of long-spacing collagen and proteoglycans present in Descemet’s 
membrane was captured in one and two degree increments at x20k magnification 
using a JEOL 1010 transmission electron microscope with Gatan ORIUS SC199 CCD 
camera. Reconstruction and segmentation was carried out on sections for a three-
dimensional insight into the structure of the long-spacing collagen present in 
Descemet’s membrane. The reconstructed image is created from projections of the 
structure of interest. Each of the images was returned to the same co-ordinates using 
centrally located fiducials to ensure each image was aligned with the previous.  
 
2.2.4.1 Alignment of the Tilt Series 
  
An important part of electron tomography is to align the collected images using the 
fiducials (gold particles). The tiff images that composed the tilt series were converted 
into a .mrc file and .st image stack. The .st file was then opened in the eTOMO 
software programme (University of Colorado, USA) to align the fiducials in each tilt 
image taken. Once the coarse and fine alignment of the fiducials is complete, eTOMO 
uses a backprojection to generate a three-dimensional reconstruction from the two-
dimensional micrographs. A tomograph is created by merging the aligned images to 
create an image that can be used to pass through the thickness of the image stack.  
 
2.2.4.2 Segmentation of Three-Dimensional Reconstruction 
 
EM3D software (Stanford University, USA) (Ress et al, 2004) was used to segment 
the final tomogram. Objects of interest were manually outlined in each image of the 
image stack. The stack with the traced objects was rendered producing a three-
dimensional reconstruction of the object of interest (Figure 2.1). Full methods used 
can be found in Electron Tomography (2006).  
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Light microscopy was also used to view DSAEK/nDSAEK samples at lower 
magnification so the entire corneal depth could be examined. Semi-thin sections of 
500 nm were cut and placed onto glass slides. Sections were stained with 1% 
toluidine blue and washed with distilled water before being analysed using a Leica 
DM RA2 photomicroscope with Leica DC 500 camera.  
 
2.3 Immunohistochemistry 
 
Immunohistochemistry was undertaken to pinpoint specific antigens (i.e. NBC) 
present in the developing avian cornea.  
 
Corneas were dissected from embryonic chicks (E8-14), placed into moulds 
containing O.C.T. compound (optimal cutting temperature) and rapidly submerged 
into isopentane cooled by liquid nitrogen and stored until required. O.C.T. embedded 
samples were mounted onto a chuck before cooling in the cryostat chamber (Bright, 
Figure 2.1 Screenshot of the segmentation and rendering process using EM3D. Segmentation 
step (left) followed by rendering process (right) to obtain the three-dimensional reconstruction.  
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OTF5000). 10m frozen O.C.T. sections were cut and placed onto glass slides (Fisher 
scientific), left briefly to dry and stored at -20C until required. Cryosections were 
drawn around using an ImmEdge (PAP) pen (Vector laboratories, UK) before 
rehydrating in PBST (0.05M phosphate buffered saline with 0.1% Tween-20). Tissue 
was fixed in cold (-20°C) ethanol (75%) for 1 minute and washed in PBST (5 min 
(x3)). Sections were pre-blocked with 5% normal goat serum before staining with 
either primary antibody or non-specific rabbit IgG for 1 hour at room temperature. 
Rabbit anti-Na
+
/HCO3
- 
cotransporter polyclonal antibody (Merck Millipore, UK) was 
diluted (1:200) as suggested by manufacturer before being added to the tissue. 
Negative controls included primary antibody omission (PBS) or substitution with a 
non-immune rabbit immunoglobulins (5mg/ml).  
 
Slides were washed with PBST (5 min) prior to incubation with the secondary 
antibody, Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen, UK), for 1 hour at room 
temperature. Further washing with PBST was carried out before mounting in 
Vectashield mounting medium containing DAPI, used as a nuclear counterstain 
(Vectashield, Vector Laboratories, Burlingame, CA). Results were analysed using 
fluorescence microscopy (BX61; Olympus, Tokyo, Japan). 
 
After examination using the fluorescence microscope, it appeared the 5% chick serum 
was adequate to reduce the non-specific binding; as a result, this step was 
incorporated in the protocol. 
 
2.4 A-Scan Ultrasonography  
 
A-scan ultrasonography was used to measure corneal thickness in the eyes of 
embryonic chicks. The system comprised a panametrics model 5073PR pulser-
receiver and a 20MHz transducer fitted with a 15mm saline stand-off perfused at 
0.05ml/min which was placed onto the fresh cornea. Readings were taken once five 
peaks were visible representing cornea, lens and retina. Readings were obtained in 
triplicate, with re-alignment between readings and recorded as they were taken. 
Ultrasound velocities were assumed to be 1.534 mm/s in the cornea. Calibration of 
the equipment was carried out daily using a water filled cuvette with known internal 
dimensions. The schematic shows the peaks present before a reading was taken 
                                                                       Chapter 2: Materials and methods  
54 
 
(Figure 2.2). One way analysis of variance and Tukey-Kramer multiple comparisons 
post-hoc test were used to determine differences between embryonic days. Two-way 
analysis of variance was used to examine the influence of two independent variables 
(left/right cornea and developmental day) on the corneal thickness. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Schematic showing the peaks observed during ultrasonography. Red-corneal peak, 
green-lens and blue-retina. Identification of all five peaks was ensured before the reading was taken 
to ensure accurate measurement. Adapted from http:/webvision.med.utah.edu/book/part-i-
foundations/simple-anatomy-of-the-retina/.  
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3. 
 
3.1 Introduction 
 
3.1.1 The Corneal Endothelium Pump Mechanism 
 
The corneal endothelium is a leaky cell layer as a result of the discontinuous zonula 
occludens that allow nutrients into the avascular stroma. The leak is counteracted by the 
removal of fluid out of the stroma to prevent oedema. In healthy cornea there is no net fluid 
transport, as fluid is actively secreted out of the cornea counterbalancing the leak of fluid into 
the cornea. This process is referred to as the ‘pump-leak’ mechanism, a feature required to 
keep the cornea at the appropriate hydration for transparency. The pump mechanism ceases in 
the absence of bicarbonate ions and is significantly diminished in the presence of carbonic 
anhydrase inhibitors (CAIs) (Hodson, 1974; Hodson and Miller, 1976). Numerous studies 
have shown a net basolateral-to-apical flux of bicarbonate (Hodson and Miller, 1976; Huff 
and Green, 1983; Wigham and Hodson 1985), a result that has highlighted bicarbonate as the 
main ion involved in endothelial fluid transport. There is also a negative trans-endothelial 
potential on the apical side of the endothelium, suggesting that there is a net transport of 
anions from the stroma to the anterior chamber. 
 
Bonanno and Giasson concluded that a novel Na
+
 dependent Cl
-
 independent Na
+
/2HCO3
-
 
cotransporter (NBC1) was present in the corneal endothelium (Bonanno and Giasson, 1992). 
Na
+
 HCO3 transport is now identifiable in numerous cell types (Romero and Boron, 1999). In 
the corneal endothelium the NBC is located on the basolateral membrane which has a 3x 
higher bicarbonate permeability than the apical membrane based on studies in cow (Sun at al, 
2000) and human corneas (Usui et al, 1999). This has led to the conclusion that NBC loads 
endothelial cells with bicarbonate on the basolateral surface. Sodium is also thought to be 
transported via the endothelial layer, from the basolateral to apical side of the membrane 
(Hodson, 1974; Huff and Green, 1981; Lim and Fischbarg 1981), and is likely to be the 
counterion (Figure 3.1). 
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There are two isoforms of NBC-1, kidney (kNBC) (Romero et al, 1998) and pancreatic 
(pNBC) (Abuladze et al, 1998), the differences between these lie within the NH2 terminal 
sequences. kNBC has a 1Na
+
:3HCO3
-
 stoichiometry favouring bicarbonate efflux from the 
cell, whilst pNBC has a 1Na
+
:2HCO3
-
 stoichiometry favouring HCO3
-
 influx. However, the 
stoichiometry of pNBC and kNBC can change depending on location and cell type, 
respectively. Studies have shown that the pNBC isoform is expressed in the corneal 
endothelium with a 1:2 stoichiometry. A cotransporter with a 1:2 stoichiometry would have 
to exist for bicarbonate influx (Bonanno and Giasson, 1992).  
 
There are three possible modes of bicarbonate efflux into the aqueous humor, 1) Cl
-
/HCO3
-
 
exchange 2) CO2 efflux and conversion to bicarbonate via membrane bound carbonic 
anhydrase IV on the apical membrane (Bonanno et al, 1999) and finally 3) via a conductive 
flux through anion channels (Sun et al, 2000). 
 
Na+
2HCO3
- HCO3 H
++ CO2 CO2
HCO3 + H
+
HCO3
Cl-Na
+
H+
CA 
2K+
3Na+
Na+
TJ
CA V
STROMA AQUEOUS
Figure 3.1 Model for endothelial ion transport. NBC loads corneal endothelial cells with HCO3
-
 from the 
basolateral (stromal) side of the membrane. HCO3
-
 entry drives the formation of carbon dioxide within the 
endothelial cell, this is catalysed by carbonic anhydrase II and inhibited by carbonic anhydrase inhibitors 
(Hodson, 1971). The carbon dioxide is transported across the apical membrane quickly due to its high 
permeability, then immediately converted to HCO3
-
 and hydrogen by membrane bound carbonic anhydrase IV. 
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3.1.2 Embryonic Corneal Thickness 
 
A series of events occur during avian corneal development that affects the thickness of the 
cornea. On E5 a rapid increase in thickness correlates with the second migration of 
mesenchymal cells resulting in a corneal thickness between 30 and 50µm. These 
mesenchymal cells are destined to become corneal fibroblasts. The trigger for cellular 
invasion is thought to be expansion of the matrix (Fitch et al, 2005) and possibly the removal 
of collagen type XI which acts as a stabilising factor, keeping the stroma in a compact state 
(Cai et al, 1994). Hyaluronate, a GAG produced on E4 (Toole and Trelstad, 1971), is also 
thought to be involved in stromal swelling post endothelial migration. By E6 the thickness of 
the stroma has increased to 100µm, the posterior of which invaded by mesenchyme. 
Fibroblasts occupying the stroma are responsible for the synthesis of the secondary stroma on 
E7 (Hay and Revel, 1969). Histology indicates that the stroma reaches a maximum thickness 
by E10, prior to a dramatic compaction between the E14 and E19 developmental period when 
water is lost. This loss increases transparency as demonstrated by spectrophotometry studies 
reporting an increase from 40% to over 95% in light transmission in the adult cornea 
(Coulombre and Coulombre, 1958; 1961; Hay and Revel, 1969). Some studies see corneal 
compaction after E9 (Coulombre and Coulombre, 1958; Hay and Revel, 1969), whilst x-ray 
diffraction studies suggest compaction after E12. Water is lost initially from envisaged 
collagen-free spaces in the corneal stroma followed by homogenous compaction of collagen 
fibrils throughout the tissue after E14 (Siegler and Quantock, 2002). Factors suggested for 
this compaction include changes in water binding components within the stroma 
(proteoglycans), increased hyaluronidase (Toole and Trelstad, 1971) and the activation of the 
NBC in the corneal endothelium.   
 
This study was carried out to determine when the NBC appeared in developmental chick 
corneal endothelium to help determine when the pump becomes activated and stromal 
dehydration occurs. This will be discussed in relation to new in situ measurement of corneal 
thickness determined using A-scan ultrasonography. Finally, TEM analysis was carried out to 
detect changes in endothelial morphology during the developmental period with focus on 
organelles likely to be associated with the pump. 
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3.2 Methods 
3.2.1 A-Scan Ultrasonography 
 
A-scan ultrasonography was used to measure corneal thickness in the eyes of embryonic 
chicks. Chicks aged between E9 and E18 were killed and immediately analysed ensuring the 
head and eyes were left fully intact before mounting and measuring using the method 
described in Chapter 2. Three separate experiments were carried out to improve the data set. 
The first measured the thickness of the cornea from E10 to E18, recorded on separate days 
requiring separate calibrations on each (data not shown). The second experiment measured 
corneal thickness in embryonic chicks aged between E9 to E18 on one day requiring one 
calibration. The second experiment was repeated with an increased n number and only 
measured thickness in the left corneas after a small difference was seen between left and right 
corneas in the previous experiments. The rationale behind these experiments was to obtain a 
more accurate measurement of the thickness changes that occur during corneal development. 
Previous thickness measurements have been carried out using histology (Hay and Revel, 
1969), a method not so reliable because of artefacts inherent within the chemical fixation 
involved. One and two-way ANOVAs with Tukey’s multiple comparison analysis was 
carried out using GraphPad (Prism version 6.00 for Windows, GraphPad Software, La Jolla 
California USA, www.graphpad.com) (Appendix I). The one-way ANOVA was used to 
compare the thickness means over the developmental period i.e. to determine if there was a 
significant difference in corneal thickness between difference developmental days (E9-E18). 
The two-way ANOVA was used to examine the effect of two independent variables on 
corneal thickness i.e. to determine if developmental day or cornea (left or right) had an effect 
on the corneal thickness.  
3.2.2 Immunohistochemistry 
 
Immunohistochemistry was carried out to pinpoint specific antigens present in the developing 
avian cornea. Fully intact corneas were embedded in O.C.T. prior to cryostat sectioning. 
Immunohistochemistry was carried out as described in Chapter 2, with a rabbit anti-
Na
+
/HCO3
- 
cotransporter polyclonal antibody (Merck Millipore, UK). Developmental days 
E10-E14 were examined (n=4).  
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Control sections containing rabbit non-immune IgG showed positive staining so the 
technique was altered to determine why the non-immune rabbit IgG was binding the tissue.  
1. The primary antibody and controls were pre-absorbed with 5% normal chick serum at 
room temperature for 1 hour (Invitrogen, UK) in an attempt to prevent non-specific 
binding in the chick tissue.  
2. Secondly, the primary antibody was diluted 1:2000 and 1:8000 to determine if the 
fluorescence intensity was the same as in 1:100 dilution previously used (to determine 
if the primary is binding ubiquitously and thus indicating no specificity for the 
endothelium). 
 
3.2.3 TEM 
 
Fertilised white leghorn eggs (Henry Stewart & Co. Ltd) were incubated at 37.5C in a 
humidified rotating chamber. At E6, 8, 10, 12, 14, 16 and 18, embryos were killed in 
accordance with the Association for Research in Vision and Ophthalmology statement for use 
of animals for ophthalmic and vision research and in agreement with local ethical rules (n≥3). 
Corneas were excised immediately and fixed before undergoing TEM as described in Chapter 
2. Several sections were collected, examined and stained on each grid from peripheral to 
central cornea. 
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 3.3 Results  
3.3.1 Corneal Thickness 
 
Histology has been used in previous experiments to determine corneal thickness changes in 
development where the tissue is dehydrated and embedded. This study measured corneal 
thickness in fresh corneal tissue using A-scan ultrasonography. A-scan ultrasonography is 
capable of measuring corneal thickness in vivo, and therefore does not require the invasive 
fixation processes. Three separate experiments were carried out to determine the changes in 
embryonic chick corneal thickness. Experiments were altered each time to improve the data 
set (see Appendix I for raw data). 
 
Measurements from the second experiment, carried out on one day, show a thickness increase 
up to E14 and a decrease immediately after (Figure 3.2A). The data was split to compare left 
and right corneas (Figure 3.2B). This highlighted differences between the data sets that led to 
the final experiment measuring left cornea only (Figure 3.3). It is speculated that the 
difference in thickness between left and right corneas was probably as a result of the time 
they were measured after death (left corneas were measured first). Thickness increased 
progressively from E9 until E12 before reaching a plateau between the E12 and E15 
developmental period, prior to a steady decrease until E18, the latest time point measured.  
 
A feature observed in all graphs was the plateau in thickness observed between E13-E15. The 
left cornea was thicker in the majority of time-points measured, some differences between 
left and right corneas were significant (E9, E10, E13, E14 and E18). This difference was 
confirmed using two-way ANOVA. The final experiment measuring left cornea only was 
carried out as a result of this difference. The n number at each developmental day was 
increased ensuring a minimum of six eyes were measured at each time point (Figure 3.3) 
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Figure 3.2 Corneal thickness measured on one day in left and right corneas. A) Average thickness of 
left and right corneal data for each embryonic day (n≥6). Significant differences were present between all 
consecutive days except E9-E10 and E17-E18 (p≤0.01). B) Thickness differences between left and right 
corneas (n≥3). Left cornea was consistently thicker than right and some of these differences were 
significant (E9, 10, 13, 14, and 18, p0.01). The difference between the thicknesses decreased as the chick 
aged. Error bars denote standard deviation. Two way ANOVA suggests that both age and cornea 
(left/right) affects the result (p≤0.01) (See appendix I).  
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Figure 3.3 Cornea thickness taken from left eye only in the final experiment with increased n number 
(n≥6). Significant differences between consecutive days include E9-E10, E10-E11, E11-E12, E15-E16 and 
E16-E17 (p≤0.01). Error bars denote standard deviation. See Appendix I for statistical test.   
100
150
200
250
300
8 9 10 11 12 13 14 15 16 17 18 19
C
o
rn
e
a
 T
h
ic
k
n
e
s
s
 (
µ
m
) 
Developmental Day 
Chapter 3: Endothelial development in avian cornea 
 
 
 
64 
 
3.3.2 Immunohistochemical Analysis 
 
Results from immunolocalisation show the presence of the NBC within the endothelial cells 
from E10-E14 (Figure 3.4). The addition of chick serum prevented non-specific binding 
observed in initial control samples. The initial analysis showed non-immune rabbit 
immunoglobulin binding to the chick cornea in endothelial cells and parts of the stroma 
where it should not be detected. This indicated non-specific binding of control rabbit IgG 
which could indicate the fluorescence observed in the test samples is as a result of non-
specific binding, a false positive result. The method was altered to include chick serum (5%) 
to the test and control samples to reduce what was thought to be non-specific binding. The 
results clearly indicate the presence of this transporter in chick endothelium which 
presumably becomes involved in the management of corneal deturgescence at this early stage 
of development.   
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B
 
E10 E12 E14 
Figure 3.4 Immunolocalisation of the NBC and nuclear stained cells using rabbit anti-NBC antibody and DAPI, respectively. Immunolocalisation revealed the NBC 
was present at all developmental stages tested A) Low and B) high magnification. n= 4.Dapi=blue, NBC=green.Scale bar=100 µm (A) and 50 µm (B), respectively.  
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3.3.3 TEM Analysis of Developing Corneal Endothelium 
 
Figures 3.6 and 3.7 show TEM images from developing chick corneal endothelium from E6-
18. Images show the differences in the cells and the changes that occur within the posterior 
stroma and Descemet’s membrane. The cells had interesting features throughout 
development, including a large population of mitochondria, the presence of vacuoles and 
interdigitations. Descemet’s membrane becomes thicker as development progresses. A sparse 
stroma visualised on E6 becomes more compact as the embryo ages. Sections from peripheral 
and central cornea were visualised for each developmental day in order to obtain a detailed 
picture of the posterior cornea (n=3).   
 
 
 
 
 
 
 
 
-ve control IgG PBS 
Figure 3.5 Negative controls for immunolocalisation of NBC in developmental cornea. Controls show 
negative staining to the primary antibody and non-random binding of secondary antibody. Scale bar= 100 µm 
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Figure 3.6 Prominent features observed in developing chick corneal endothelium (E6-E10). Descemet’s 
membrane accumulation (arrows) and stroma (S) are highlighted. Vacuoles (*) and mitochondria (arrowheads) 
were also a common feature in the cell layer, together with keratocytes (◊). Scale bars=500 nm, n=3. 
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Figure 3.7 Prominent features observed in developing chick corneal endothelium. Membrane 
interdigitations were present at all stages of development (arrowheads). Vacuoles (*) were also a common 
feature in the cell layer, together with rough endoplasmic reticulum (arrow). S-stroma, DM-Descemet’s 
membrane. Scale bars=500 nm, n=3. 
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3.4 Discussion 
 
3.4.1 Thickness Changes during Avian Corneal Development 
 
After the initial thickness experiment a second was carried out in one day to decrease 
possible experimental error caused by multiple calibrations. Significant differences between 
consecutive days were seen at every stage with the exception of E9-10 and E17-18. The data 
was split to determine if there was a difference between left and right corneas (Figure 3.2B). 
A number of significant differences were observed between the left and right corneas in this 
experiment. One reason for this difference may be experimental; the left cornea was always 
measured first, a procedure that may have resulted in the drying out of the right cornea. There 
may be developmental differences between the two eyes at this stage, however, it would seem 
that corneal drying would likely be the predominant effect. The difference was more 
noticeable in younger embryos, a result probably due to the absence of eyelids and therefore 
decreased protection against drying. Due to this difference, the experiment was modified 
once more measuring only left corneas, removing external factors. The n number at each 
developmental day was increased so a minimum of 6 chicks were used at each stage. Three 
areas of interest were observed in these experiments, an initial increase, followed by a plateau 
and finally a decrease in thickness. There were 5 significant differences observed between 
consecutive days in this final experiment. These differences present were between E9-E10, 
E10-E11, E11-E12, E15-E16 and E16-E17 (p0.01). Significant differences occurred in the 
early and late stages of development where the thickness changed most dramatically. There 
were no significant differences between the E12-E15 developmental period, the thickness 
plateaued during this stage before decreasing again, probably due to the loss of water and 
homogenous compaction of collagen fibrils (Siegler and Quantock, 2002). 
 
In all experiments standard deviation was higher in the early embryonic stages due to the 
difficulty in obtaining measurements in the smaller eyes. Thickness measurements were 
similar to those measured in the final experiment.  
 
The increase in thickness from E9-E12 is thought to occur as a result of the swelling period 
that occurs on E5 in preparation for the invasion of mesenchymal cells destined to become 
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the corneal keratocytes (Hay and Revel, 1969). These data correlates with studies by Siegler 
and Quantock (2002) showing changes in the interfibrillar spacing and hydration within the 
cornea throughout the developmental period. Interfibrillar Bragg spacing was significantly 
reduced between E16-E17. A sharp, rather than a gradual, decrease in spacing was observed, 
E16 (66.8 nm) and E17 (61.2 nm). A decrease in thickness post E15, thought to be as a result 
of dehydration and compaction, could be responsible for the increase in transmission 
(Coulombre and Coulombre, 1958). Hydration was also measured in Siegler’s study, 
decreasing between E12 and E18 as the matrix becomes more compact. Siegler proposed a 
two stage dehydration, firstly between E13-E14 and secondly between E16-E17. The first 
dehydration was not accommodated by any change in centre-to-centre collagen fibril Bragg 
spacing so a different method of matrix compaction must occur. They concluded that this was 
a loss of water from non-collagenous regions, or regions of irregular collagen, such as 
stromal lakes. The second dehydration observed between E16-E17 correlated with a 
reduction in interfibrillar Bragg spacing. Therefore, the drop in hydration was attributed to 
the homogenous reduction in average spacing between the regularly arranged collagen fibrils 
which contribute to the matrix compaction (Siegler and Quantock, 2002). The hydration 
change which had the predominant effect on thickness was perhaps when interfibrillar 
spacing was reduced between E16-E17.  
 
These data not only correlates with interfibrillar collagen spacing but also with transmission 
data collected by a colleague previous to this set of experiments (Figure 3.8). Data showed a 
steady increase in transmission post E14, this increase corresponds to the decrease in 
thickness we observe post E15. The plateau in thickness during the E12-E15 developmental 
period is possibly a sign of stromal reorganisation where the collagen fibrils are arranged in 
their specific locations ready for the onset of transparency.  
 
 
 
 
 
 
 
 
Chapter 3: Endothelial development in avian cornea 
 
 
 
71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The most likely reason for the dehydration after this period is to attain optimal water content 
and interfibrillar spacing, discussed previously, required for transparency in the latter stages 
of development. This feature coincides with increased transmission (Coulombre and 
Coulombre, 1958), an outcome that is probably due to the combined effect of dehydration 
and the increased regularity of stromal collagen. 
 
New methods measuring CCT are available, including Optical Low-Coherence Reflectometry 
(OLCR). OLCR measures corneal thickness on the basis of temporal separation of a low-
coherent infrared laser beam reflected from the anterior and posterior surfaces of the cornea. 
Some studies have found significant differences between ultrasound pachymetry and OLCR 
measurements whilst others report similar measurements in both (Airiani et al, 2006). Most 
would agree that ultrasonography is an accurate technique with good reproducibility (Rainer 
et al, 2002), however, techniques including OLCR offer a non-contact method alongside 
rapid measurements. These additional features were not of primary importance in our 
experiments. The chicks were dispatched immediately so contact of the saline with the cornea 
was not a major concern. The main objective in this study was to obtain a more accurate 
picture of the thickness changes that occur during development, a feature that has only been 
measured previously by histology (Hay and Revel, 1969). Since ultrasonic pachymetry is the 
most commonly used method in patients and data exists using this method on hatched chicks 
(Montiani-Ferreira et al, 2004) this system seemed appropriate. 
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Figure 3.8 Light transmission at 550nm wavelength during the E12-E18 developmental period showing 
an increase post E14. Error bars illustrate standard deviation. Data obtained from Dr. Barbara Palka.  
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Results obtained using histology showed a maximum thickness at E9 (220 m) and a 
decrease thereafter due to dehydration so that by E14 the thickness reached 150 m (Hay and 
Revel, 1969). The study carried out by Hay and Revel showed considerable variation on E14 
which was concluded to be as a result of variations in fixation or differences in water content 
at this developmental stage (Hay and Revel, 1969). Histological measurement of thickness 
can be inconsistent as the stroma has a tendency to compress and stretch during cutting. A 
true reading of the thickness can also be hindered by the fixation and dehydration processes.  
 
The fluctuations in corneal thickness in our results imply there is a factor playing a role in 
stromal hydration/collagen organisation during embryonic development. The localisation of 
the NBC in the corneal endothelium (discussed later) supports the hypothesis that this 
cotransporter is influencing thickness at these early stages, especially during thickness 
decrease. As mentioned above, compaction and dehydration do occur in the embryonic 
cornea, thus, may be regulated by the NBC.  
3.4.2 NBC Localisation during Avian Development 
 
The bicarbonate ion is now agreed to be the main ion involved in endothelial fluid transport 
(Hodson and Miller, 1976; Jentsch et al, 1985; Bonanno and Giasson, 1992; Riley et al, 1995; 
Bonanno, 2003). Bicarbonate is transported through the NBC present in the basolateral 
membrane of the corneal endothelium (Sun and Bonanno, 2003). Immunolocalisation 
revealed the presence of NBC at all stages tested (E10-E14) (Figure 3.4), however, functional 
studies would have to be carried out to determine activity. It is already known that this 
transporter is important for corneal transparency later in life but it may also be involved in 
corneal compaction and dehydration in development. The results obtained support these 
claims, together with previously reported data on the expression of multiple genes, including 
NBC, in the developing avian cornea (Conrad et al, 2006). Conrad found that the NBC gene 
increased 10-fold through development into adult corneas in the chick model. mRNA 
expression was determined using real-time PCR using CDNA produced whole-cell RNA 
(Figure 3.9) (Conrad et al, 2006).  
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They found the largest increase in the NBC gene was between E7 and E14 (Figure 3.9), 
however, a difference in fluorescence was not observed in our data. A quantifiable technique 
is necessary to determine at what point the total amount of protein that is required is being 
expressed in the endothelium. The data suggests the NBC gene present, at the latest E7 
(Conrad et al, 2006), has produced the cotransporter by at least E10 according to our data. 
Together, these data suggest that the NBC gene expression increases steadily during 
development and, based on our analysis, is localised within the endothelial cells. Both studies 
provide evidence that the NBC may be important in the developmental period. Gene 
expression increased until 4 weeks post hatching in Conrads study, the gene may increase 
into the adult cornea to produce more of the NBC required for transparency, however, light 
transmission is thought to reach 96% by E19 (Coulombre and Coulombre, 1958). Perhaps is 
it further unregulated to supply the growing demands and increase in size that occurs in the 
adult cornea, nevertheless, the change is minimal compared to that in the developmental 
period which is of more interest to us. The evidence presented here together with Conrad’s 
study suggests that NBC has the potential to drive corneal dehydration during development.  
 
Figure 3.9 Expression of genes involved in endothelial cell transport using real-time PCR. NBC (red 
triangles) increased steadily during the developmental period before plateauing post E18. Results normalised to 
GAPD expression. Adapted from Conrad et al, 2006. 
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3.4.3 TEM of Developing Endothelium 
 
Several findings were observed in the embryonic chick cornea including high volumes of 
mitochondria, interdigitations within the endothelial cell membranes and thickening of the 
adjacent Descemet’s membrane. Descemet’s membrane is secreted by the endothelial cells 
once they have formed a complete monolayer on E5. The membrane begins to form on the 
endothelium’s anterior surface on E6, thickening during development and throughout 
adulthood. Golgi bodies are also seen in many of the micrographs, an organelle responsible 
for manufacturing the proteins that comprise Descemet’s membrane. Together with the RER 
(Figure 3.7), these organelles have important roles within the cell and in the formation of the 
primary stroma and Descemet’s membrane via protein synthesis and migration. 
Interdigitations (Figure 3.7) are foldings of the endothelial cell surface, a feature thought to 
preserve excess cell membrane which can be used later in development and post hatching. 
The surface of endothelial cells increases as the eye grows and this is associated with cell 
spreading and as a result, fewer interdigitations (Materson et al, 1977). Vacuoles are also 
predominant in endothelial cells at all developmental stages. Whilst they are an organelle that 
can represent a manifestation of cellular activities, including the uptake of fluid, they may 
also represent post-mortem bleb formation (Speakman, 1959). It is thought that normal cell 
function would be difficult if the cell were so severely vacuolated. Other noticeable 
organelles are the mitochondria which are abundant in endothelial cells. They are responsible 
for the energy supply, the majority of which is directed towards the pumping mechanism in 
endothelial cell membrane. In addition to endothelial and Descemet’s membrane changes, the 
stroma undergoes alterations as development progresses. The posterior stroma is sparse 
(Figure 3.6 [E6]) in the early developmental period, fewer fibrils are present, arranged in a 
disorganised manner compared to those seen later in development. By E18 the stroma is 
dense with regularly arranged collagen fibrils required for transparency (Figure 3.6 [E18]). 
  
This chapter outlines significant changes that occur within the cornea during the 
developmental period and the potential mechanisms behind these alterations. The NBC is 
recognised to be one of the key components of the endothelial pump mechanism, this chapter 
further validates this component and discusses the possibility that it may play a role in the 
developmental context. 
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4. 
 
4.1 Ultrastructural Analysis of Descemet’s Membrane  
 
Descemet’s membrane is the corneal endothelium’s basement membrane which in the healthy 
cornea consists of an anterior banded layer and posterior non-banded layer (Figure 4.1). The 
anterior banded zone is composed of thin collagens fibrils with a periodicity of 110 nm 
produced during fetal life. The posterior non-banded zone is an amorphous assembly of 
extracellular matrix located between the anterior banded zone and the corneal endothelium. 
Descemet’s membrane has been shown to contain hexagonal lattices aligned in parallel to the 
membrane surface (Jakus, 1956). The lattice is composed of electron dense nodes and rod-
like structures measuring 132 nm in length which are now recognised to be type VIII 
collagen (Sawada et al, 1990). Type VIII collagen is a non-fibrillar short-chain collagen 
originally identified as a product of endothelial cells from bovine aorta (Sage et al, 1983) and 
rabbit corneal endothelial cells (Benya, 1980), and initially called endothelial collagen (Sage 
et al, 1983).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Schematic of Descemet’s membrane alongside a type VIII hexagonal lattice. (A) Descemet’s 
membrane is composed of an anterior banded layer (A) adjacent to a posterior non-banded layer (P).  (B) The 
posterior layer is arranged as a lattice whereby collagenous filaments forma polygonal network (Bron et al, 
1997). (C)Descemet’s membrane is recognised to be composed of hexagonal lattices consisting of collagenous 
(132 nm) and non-collagenous regions. Possible type VIII constructs are presented including parallel and anti-
parallel conformations. (D,E) Immunoelectron labelling of the lattice network produced by cultured  bovine 
corneal endothelial cells (Sawada et al, 1990).  S-stroma, DM-Descemet’s membrane, EN-endothelium. 
(Taken from DelMonte and Kim, 2011; Shuttleworth, 1997).  
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Two distinct chains exist for type VIII collagen; α1(VIII) and α2(VIII). A heterotrimeric form 
of type VIII collagen is present in Descemet’s membrane with a chain composition of 
[α1(VIII)2 α2(VIII)1] (Mann et al, 1990). The triple helix of collagen type VIII is flanked by 
non-helical N (NC2) and C (NC1)-terminal domains. The construction of type VIII is thought 
to help in maintaining an open structure, which consequently stabilises basement membranes 
(Yamaguchi et al, 1989). This is an important property in Descemet’s membrane which has to 
be able to allow the movement of fluid, whilst being able to handle compression.  
 
The main techniques used to visualise collagen type VIII have been two-dimensional, hence, 
little is known about the way in which it is packed and how it arranges itself through the 
depth of the Descemet’s membrane. Whilst studying the corneal endothelium noticeable 
elongated structures were observed in Descemet’s membrane. The first part of this chapter 
investigates the ultrastructure of Descemet’s membrane in mice using electron tomography to 
gain a greater understanding of these elongated structures and the general arrangement of 
Descemet’s membrane. The second part focuses on the ultrastructure of Descemet’s 
membrane in murine corneas with collagen type VIII mutations.  
 
4.1.1 Methods 
 
5-month old mouse corneas were fixed for 2-3 hours at 4°C prior to general TEM embedding 
as described in Chapter 2. Ultrathin sections of embedded corneal tissue were cut at 100 nm 
and 120 nm thickness for transmission electron microscopy and electron tomography, 
respectively, and collected on uncoated copper grids. 1% phosphotungstic acid and a 
saturated uranyl acetate solution were used to stain the grids for 2 and 12 minutes, 
respectively, prior to examination in an electron microscope (JEOL 1010 transmission 
electron microscope with Gatan ORIUS SC100 CCD camera). Samples undergoing electron 
tomography (n=3) were also exposed to colloidal gold solution (10 nm-BBL, Cardiff, UK) 
which was applied to each face of the sections to serve as fiducial markers for later image 
alignment (details in chapter 2).  
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  4.1.2 Results 
 
Electron tomography was carried out on transverse and en face orientations of Descemet’s 
membrane. Analysis revealed elongated structures in transverse sections, whilst polygonal 
and elongated structures appeared when en face orientated sections were examined (Figure 
4.2) Figure 4.3 displays the structures present in Descemet’s membrane with an annotated 
micrograph highlighting what are believed to be the collagenous and globular regions. The 
supplementary material attached to this thesis shows ImageJ movies of elongated and 
pentagonal structures (see CD). Initial analysis used transverse sections of Descemet’s 
membrane where elongated structures with a periodicity of 100 nm were identified. On closer 
inspection these structures had a weaker intermediate band located centrally between the 
distinct elongated bands, (Figure 4.4). Globular domains of the same polygonal structure are 
thought to be responsible for this band, but are likely to be in a different plane.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 En face micrographs of Descemet’s membrane. (A) Low mag image of the membrane where 
polygonal structures have been boxed (scale bar=500 nm). (B)(C) High mag images of polygonal structures (scale 
bar=100 nm and 500 nm, respectively) where black lines represent collagen in (D) (E) (scale bars=100 nm and 500 
nm, respectively).  
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Figure 4.3 The morphology of Descemet’s membrane in en face sections. Original (A) and annotated (B) 
micrographs of the structures observed in Descemet’s membrane. Black lines represent the collagenous 
regions whilst yellow and orange circles signify the globular domains. Scale bar=100 nm. 
  Chapter 4: The ultrastructure of Descemet’s membrane and the structural changes in the 
cornea of Col8a2 transgenic knock-in mice  
 
 
80 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Presence of an intermediate band in Descemet’s membrane. Elongated structures (A) imaged 
in transverse sections of Descemet’s membrane had less distinct intermediate band (arrowheads). Based on the 
polygonal formations in en face sections (B) it is likely that the elongated structures observed in the transverse 
plane are stacked globular domains. This is also true of the less distinct intermediate band, produced from a 
globular domain in a different plane i.e. central globular domain (arrowhead). Scale bar=100 nm 
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A three-dimensional reconstruction was used to obtain a more detailed view of Descemet’s 
membrane (Figure 4.5). This allowed a model of Descemet’s membrane to be developed 
(Figure 4.6) which illustrates possible constructs of collagen type VIII.  
 
 
 
 
 
 
 
 
 
 
                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 Reconstructed images of type VIII collagen arranged in its polygonal lattice in 
Descemet’s membrane. En face sections show the polygonal lattice (squared) in Descemet’s membrane 
(A) and the appearance of the lattice when tilted (B). The arrowheads (B) point to the separate globular 
domains which are not visible in (A). Scale bar=100 nm. 
A 
B 
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Cuprolinic blue stained corneas revealed that proteoglycans were present in Descemet’s 
membrane and more specifically the internodal regions of collagen type VIII. A -60˚ to +60˚ 
single-axis tilt series was captured every two degrees to examine if the proteoglycans interact 
with type VIII collagen (Figure 4.7).  
 
Figure 4.6 Schematic representation of type VIII collagen arrangement in Descemet’s membrane. Type 
VIII collagen forms polygonal lattice structures that lie parallel to the surface of the membrane. The schematic 
relates the two-dimensional micrographs to the three-dimensional reconstruction of type VIII. Electron 
micrographs (EM) show polygonal and longitudinal structures viewed in en face and transverse orientation, 
respectively. Schematic representation of these structures are displayed directly below. The bottom schematic 
outlines collagen VIII composition. NC1 and NC2 domains (orange and yellow circles) are flanked by a 
collagenous domain (black).  
 
 
SHOW hex and pent structures 
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Figure 4.7 Proteoglycans present in Descemet’s membrane. A) Cuprolinic blue stained corneas revealed 
proteoglycans were present in Descemet’s membrane and appeared to bind to collagen type VIII. B) Stereo 
pairs of type VIII collagen in Descemet’s membrane. Blue=globular domains, yellow=proteoglycans. Scale 
bars=50 nm and 100 nm, respectively.  
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4.1.3 Discussion  
 
Transverse sections observed using electron tomography revealed long-spacing structures 
present in Descemet’s membrane. The structures had a periodicity of 100 nm and therefore 
were initially assumed to be collagen type VI. However, after re-orientating the block face 
polygonal formations were observed implying the structure was more likely type VIII 
collagen, in agreement with previous literature (Sawada et al, 1990; Akimoto et al, 2008). As 
well as polygonal formations, the long-spacing structures were still visible (Figure 4.2 & 4.3). 
This suggests that type VIII collagen forms polygonal and linear structures. The proposed 
model involves a polygonal lattice with a linear component based on three-dimensional 
analysis with ImageJ (Figure 4.6). When viewed in transverse, globular domains stack 
perpendicularly to the membrane, but were viewed more frequently lying in parallel to the 
membrane surface. The elongated structures observed are thought to be components of the 
polygonal lattice. This was the case in some instances when the samples were tilted. 
However, other samples remained elongated and no visible lattice formation was observed. 
The presence of elongated structures would still allow the movement of fluid through the 
membrane in and out of the stroma whilst assisting in resisting compression. There are 
various studies who suggest a hexagonal type VIII construct exists in Descemet’s membrane. 
Sawada and colleagues employed antibodies that bound to the nodal regions of both a 
hexagonal and long spacing linear structures produced by cultured endothelial cells in an 
immunogold labelling study (Yamaguchi et al, 1989; Sawada et al, 1990). There is also clear 
evidence that type X collagen, the other non-fibrillar, short chain collagen, forms hexagonal 
structures within cartilage extracellular matrix (Kwan et al, 1991). Type X and VIII collagen 
share striking structural similarities at nucleotide and amino acid level implying that their 
constructs are likely to be similar together with several studies reporting the type VIII 
hexagonal lattice that exists in Descemet’s membrane (Sawada et al, 1984; Kapoor et al, 
1988; Sawada et al, 1990). 
 
Occasionally, interbands were present within the elongated transverse forms of the type VIII 
collagen molecule (Figure 4.4). After imaging en face sections it was concluded that these 
interbands are probably formed by the central globular domain observed in the polygonal 
formations. As mentioned previously, stacked globular domains are thought to form the 
dominant bands, this is likely to be true for the intermediate bands one observes in transverse 
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sections of Descemet’s membrane. However, the less distinct banding is probably due to 
globular domains not being in the same plane as the distinct bands, hence, a weaker structure.  
The presence of proteoglycans within Descemet’s membrane was also observed. Cuprolinic 
blue-stained corneas revealed that proteoglycans were distributed throughout the membrane, 
and in particular in association with type VIII collagen (Figure 4.7). Proteoglycans appeared 
in the internodal regions of the type VIII collagen in two-dimensional micrographs. Three-
dimensional reconstruction confirmed the presence of proteoglycans at the internodal regions 
suggesting that they are likely to bind to the helical part of type VIII collagen. However, 
previous studies have speculated that it is the non-collagenous domains (NC1 and NC2 of 
α1(VIII) collagen) that are most likely to bind negatively charged components of the 
extracellular matrix due to their high isoelectric point (Rosenblum et al, 1993). The binding 
of proteoglycans to this collagen, whether to the collagenous or non-collagenous region, may 
assist in maintaining the arrangement of type VIII in either the polygonal lattice or the linear 
structures observed via the collagenous regions of the molecule. 
 
These results support previously reported literature on the structure of Descemet’s membrane. 
The three-dimensional reconstruction suggests that there is also a linear arrangement of type 
VIII collagen within Descemet’s membrane. Proteoglycan labelling in Descemet’s membrane 
has been previously reported (Bairaktaris et al, 1998; Davies et al, 1999), however, this is the 
first data that shows proteoglycans associating with internodal regions of type VIII collagen 
in Descemet’s membrane. This may imply they have a role in maintaining the unique 
structure of type VIII collagen in membranes such as Descemet’s.  
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4.2 Fuchs’ Endothelial Corneal Dystrophy  
 
The posterior corneal endothelium is an important cell layer and its main role is to maintain 
stromal deturgescence. Disruptions in this cell layer, as a result of endothelial dystrophies, 
trauma, infection or surgery, result in corneal swelling and consequently vision loss. Fuchs’ 
endothelial corneal dystrophy (FECD) is an inherited progressive disorder that leads to visual 
disability and is one of the most common indications for penetrating keratoplasty (PK) 
(Adamis et al, 1993). Symptoms are revealed between the fifth and seventh decade of life in 
the late-onset form of the disease. These include Descemet’s membrane thickening, a 
decrease in endothelial pump sites and stromal edema (Waring, 1982). A rare early-onset 
form of FECD arises between the third and fourth decade of life with the progressive 
development of corneal decompensation similar to that present in late-onset FECD.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In late-onset FECD, the anterior banded layer, and posterior non-banded layer are anterior to 
a pathologic posterior banded layer which is not ordinarily present. Whilst the posterior non-
Figure 4.8 TEM of Descemet's membrane in normal and Fuchs’ (COL8A2L450W/L450W) patients. A) 
Normal B) Late-onset C) Early-onset Descemet's membrane. ABL-anterior banded layer, PNBL-posterior 
non-banded layer, PBL-posterior banded layer, ICL-internal collagenous layer PSL-posterior striated layer. 
(Gottsch et al, 2005).  
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banded layer is normal in the early-onset mutant, the anterior banded layer is thicker. There is 
also an internal collagenous layer, and a posterior striated layer (Figure 4.7).  
 
Collagen VIII is a short-chain collagen, highly expressed in normal Descemet’s membrane 
(Kapoor et al, 1988) and its quaternary structure has been elucidated in the first part of this 
chapter. Recently, a disorganised form of collagen type VIII has been associated with early-
onset FECD (Gottsch et al, 2005). In Descemet’s membrane, type VIII collagen is a 
heterotrimer composed of α1(VIII)2 and α2(VIII) (Shuttleworth, 1997). These form stacked 
polygonal lattice-like structures arranged in parallel to Descemet’s membrane surface, 
thought to be important in resisting compression.  
 
FECD models have recently been developed to investigate the α2 collagen VIII gene 
(COL8A2) responsible for encoding the α2 chain of type VIII collagen (Biswas et al, 2001; 
Gottsch et al, 2005). Collagen VIII accumulation in FECD, and the identification of a 
COL8A2 gene mutation in an early-onset FECD family (Biswas et al, 2001; Gottsch et al, 
2005) has highlighted the importance of this collagen in the early-onset form of the disease.  
 
Single amino acid mutations in the COL8A2 gene result in increased collagen VIII 
accumulation thought to be injurious to the corneal endothelium. Point mutations in the 
COL8A2 gene give rise to different forms of FECD, these include the COL8A2
L450W/L450W
 
(Gottsch et al, 2005) and the COL8A2
Q455K/Q455K
 mutation. A leucine to tryptophan  mutation 
at position 450 (Leu450Trp or L450W) (Gottsch et al, 2005) and a glutamine to lysine at 
position 455 (Gln455Lys or Q455K) (Biswas et al, 2001) are responsible for altered collagen 
VIII. The COL8A2
L450W/L450W 
mutation correlates with intra-endothelial cell and extracellular 
matrix collagen VIII accumulation whilst the mechanism behind the COL8A2
Q455K/Q455K 
form 
is not yet fully understood (Zhang et al, 2006). Zhang and colleagues found no significant 
amount of other components, such as fibronectin and collagen IV, within the endothelial cell 
in early-onset FECD suggesting that they are secreted rapidly whilst collagen type VIII is 
retained.  
 
FECD advances over decades with a lack of symptoms in the early disease states. As a result, 
early pathological tissue is unobtainable leaving unanswered questions about the initial 
pathogenesis of the disease. A number of studies have started looking at the COL8A2 gene 
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mutations to determine their effects. Recently, a murine, early-onset FECD disease model has 
been generated with Col8a2 mutations (Col8a2
Q455K/Q455K 
and Col8a2
L450W/L450W
) in an 
attempt to identify if the unfolded protein response (UPR) was activated as previously 
confirmed in late-onset FECD (Engler et al, 2010). Accumulation of misfolded protein results 
in endoplasmic reticulum (ER) stress, a feature that is toxic to cells. Activation of the 
unfolded protein response counteracts this condition by reducing the unfolded protein 
(Szegezdi et al, 2006).  Col8a2
Q455K/Q455K
 mutant mice show a 27% endothelial cell decrease 
at 5 months whereas Col8a2
L450W/L450W
 show a 10% reduction in endothelial cell numbers 
(Jun et al, 2012). These knock-in mutant mice represent the first realistic in vivo models for 
FECD that will allow investigation into the early-onset disease pathogenesis (Jun et al, 2012). 
The aim of the second part of this chapter was to extend these findings by investigating if the 
homologous mutations affect the architecture of the corneal extracellular matrix at 5 months 
of age. Human and mice have similar Descemet’s membrane including anterior banded and 
posterior non-banded zones which makes the mouse model a valuable model when analysing 
disease. 
 
4.2.1 Methods 
4.2.1.1 Col8a2 knock-in mice 
 
The mouse Col8a2 gene displays 94% amino acid identity to the human COL8A2 gene 
(protein BLAST, http://blast.ncbi.nlm.nih.gov/Blast.cgi). A targeting vector containing the 
specific regions of the Col8a2 gene was subcloned into a pBK-CMV vector to generate a 
gap-repair plasmid. The transformants then had the Q455K substitution (C to A nucleotide) 
introduced by mutagenesis using specific primers. The vector was verified, embryonic stem 
cell electroporation and blastocyte injection was performed. Heterozygous were crossed with 
a Sox2-cre line (Jackson Labs, Bar Harbor, ME) prior to breeding to obtain homozygous WT 
and MUT genotypes. Generation of the Col8a2 knock-in mice was carried out in Dr Albert 
Jun’s laboratory (Johns Hopkins University, Baltimore, MD, USA). Corneas from 
Col8a2
Q455K/Q455K
 and Col8a2
L450W/L450W 
were examined alongside age/sex-matched 
homozygous WT littermates to ensure any phenotypes of the mutation occur as a result of 
mutation and not because of other confounding factors related to genetic background 
differences. For details please see Jun et al, 2012. 
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4.2.1.2 TEM 
 
Half corneas from 5-month old wild type and mutant mice, Col8a2
Q455K/Q455K 
and 
Col8a2
L450W/L450W 
as published by Jun and colleagues (2012) were prefixed in 4% 
paraformaldehyde in 1xTris acetate buffer for 10 minutes prior to incubation with 
glycosaminoglycan (GAG) specific degrading enzymes. Corneas were incubated with i) 
keratanase ii) chondroitinase ABC or iii) keratanase and chondroitinase ABC for 4 hours to 
distinguish between keratan sulphate (KS) and chondroitin/dermatan sulphate (CS/DS) 
proteoglycans. Following enzyme treatment, corneas were rinsed in sodium acetate/0.1M 
magnesium chloride buffer prior to fixation overnight in 2.5% glutaraldehyde in 25mM 
sodium acetate buffer (pH 5.7) containing 0.1M MgCl2 and 0.05% Cuprolinic blue. 
Embedding was then carried out as described in the general methods section. Ultrathin 
sections of embedded corneal tissue were cut at 100 nm thickness for transmission electron 
microscopy and collected on uncoated copper grids. Orientation of the tissue was arranged so 
that peripheral tissue was collected first followed by central cornea. Several sections were 
collected on multiple girds for each region so micrographs would show accurate 
representation. A 1% phosphotungstic acid and a saturated uranyl acetate solution were used 
to stain the grids for 2 and 12 minutes, respectively, prior to examination in an electron 
microscope (JEOL 1010 transmission electron microscope with Gatan ORIUS SC100 CCD 
camera). Several grids with sections from peripheral-to-central and anterior-to-posterior 
cornea were examined for each sample (n=4). 
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4.2.2 Results 
 
4.2.2.1 Endothelial Examination of Col8a2 Mutant Mice 
 
Specular micrographs taken at 5-months immediately after euthanasia and just prior to 
excision of the cornea from the eye and its processing for electron microscopy with or 
without enzyme digestion were used to determine changes in cell shape, size and number. 
Micrographs revealed darker cells and punctate guttae in both mutants but slightly more so in 
the Col8a2
Q455K/Q455K
 strain (Figure 4.9). Multiple sections of the mutant endothelium were 
imaged using TEM (Figure 4.10). These showed sparse organelles identified as dilated RER 
that were not present in wild type mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 Specular micrographs of corneal endothelium. Specular micrographs show punctate guttae and 
abnormal darkened cells in both mutant strains (*). Scale bar=50 µm. Images taken by Ms Huan Meng.  
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Figure 4.10 TEM of corneal endothelium in wild type and Col8a2 mutants. Both mutants had dilated 
RER (arrowhead) present in their endothelial cells when compared to wild type. DM-Descemet’s 
membrane, St-stroma. Scale bar=500 nm. 
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  4.2.2.2 TEM analysis of Col8a2 mutant stroma 
 
Micrographs (Figure 4.11) show the anterior and posterior stroma of the Col8a2
Q455K/Q455K 
and Col8a2
L450W/L450W 
mutant mouse corneas. No 
obvious stromal oedema was observed but regions of focal oedema were present in the Col8a2
Q455K/Q455K 
mutant. More obvious differences were 
noted in Descemet’s membrane and the endothelial cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 TEM 
micrographs of 
Col8a2
L450W/L450W 
and 
Col8a2
Q455K/Q455K
 homozygous 
knock-in gene mutant mouse 
stroma stained with 
Cuprolinic blue. Focal 
oedema was observed in the 
posterior of the 
Col8a2
Q455K/Q455K 
mutant. 
Micrographs taken from depth 
of cornea (anterior to 
posterior). Scale bar=100 nm.. 
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TEM revealed differences in the levels of proteoglycans present in Descemet’s membrane 
and the endothelial monolayer where samples had been stained with Cuprolinic blue. More 
proteoglycans were noted at the Descemet’s endothelial interface in the Col8a2 mutants 
compared to wild type samples. The amount of Cuprolinic-blue staining of proteoglycans 
varied between endothelial cells but was consistently higher in the mutant corneas (Figure 
4.12). After observing a higher number of proteoglycans at the Descemet’s endothelial 
interface in the Col8a2
Q455K/Q455K 
mutant, the same interface, after enzyme digestion 
(keratanase and chondroitinase ABC), was examined to determine if the proteoglycans 
remained (Figure 4.12). This suggested that another proteoglycan, not digested by enzymes 
employed in these studies, is present at the Descemet’s endothelial interface 
. 
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Figure 4.12 Differences in proteoglycan distribution at the Descemet’s endothelial interface of wild type and mutant mice. Proteoglycans with (top) and without 
(bottom) enzyme digestion (keratanase plus chondroitinase ABC) at the Descemet’s endothelium interface in wild type (WT), Col8a2L450W/L450W (L450W) and 
Col8a2
Q455K/Q455K 
(Q455K). Large amounts of proteoglycans (arrowheads) were observed in the Col8a2
Q455K/Q455K
 mutants, compared to wild type. Scale bars =200 nm. 
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4.2.3 Discussion 
 
Previous mouse models, including a double knock-out Col8a2 mutant strain, have shown 
decreased cell density in the endothelial layer, however, this was the only similarity to FECD. 
No Descemet’s membrane thickening or guttae were observed in single or double Col8a2 
knock out mouse models, which are normally seen in the disease (Hopfer et al, 2005). A 
more recent mouse model showing pathological similarities to those seen in the human form 
of FECD has now been developed. Results from this model show decreased endothelial cell 
counts, endothelial cell morphologic changes and Descemet’s membrane guttae in their 
Col8a2
Q455K/Q455K
 mutant mouse (Jun et al, 2012). This model may provide a clearer picture 
into the mechanisms of early-onset FECD. A pathophysiological hypothesis, based on the 
above mutations, is that the amino acid substitutions decrease the turnover of Col8a2 leading 
to an abnormal accumulation of collagen type VIII in Descemet’s membrane. Subsequently, 
this could be a reason for the injurious effects on endothelial cells resulting in apoptosis. This 
study utilised TEM to determine the effects the Col8a2 mutations on the corneal stroma, 
including collagen organisation and proteoglycan distribution, Descemet’s membrane and the 
endothelium.  
 
4.2.3.1 Col8a2 Mutants 
 
Results show TEM of the stroma in both Col8a2
Q455K/Q455K
 and Col8a2
L450W/L450W
 mutants, 
whose missense mutations have been associated with the early-onset form of FECD (Biswas 
et al, 2001). There were no obvious signs of widespread oedema in the stroma, but focal 
oedematous regions were present in the posterior stroma of the Col8a2
Q455K/Q455K
 mutant 
(Figure 4.13). The relatively young age of the mice is a possible explanation for the lack of 
widespread oedema, the effects of FECD may not be apparent at this 5-month time point. 
There are a lack of symptoms in the early stages of FECD despite clinical evidence (guttae, 
Descemet’s membrane thickening) identifying disease onset. This suggests that stromal 
oedema occurs later on in the disease course when membrane thickening and guttae begin to 
affect the endothelial cells and consequently stromal hydration. Guttae, thought to cause 
endothelial degeneration, have been reported at this stage (Jun et al 2012), but these were 
difficult to locate. Thus, it is likely that the focal posterior oedema is a consequence of the 
young age of the mice and will possibly increase with time. A study carried out on patients 
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found that the majority had no or very few guttae, concluding that guttae may be forming but 
are ‘re-surfaced’ by an increasing secretion of collagen into Descemet’s giving the 
appearance of a uniform surface (Zhang et al, 2006). This may be the case in these mouse 
samples, a result which could be easily overlooked.  
 
4.2.3.2 The Effect of Col8a2 Mutations on Endothelial Cells. 
 
Jun’s studies reported a 27% reduction in endothelial cell count at this 5-month time point 
(1522±241 versus 2137±155 cells/mm
2
, mean ± standard deviation) and a 41%  reduction 
(1240+265 versus 2101+120 cells/mm
2
) at 10-month in Col8a2
Q455K/Q455K
 versus wild type 
mice (Jun et al, 2012). It is evident that the mutation affects the endothelial cell count; a 20% 
reduction is seen between the 5 and 10-month period alone. Nevertheless, it appears that 
migration and enlargement, a known occurrence in these cells, makes up for the lack of 
mitosis in response to cell death. This mechanism allows the monolayer to stay confluent 
with sufficient pump activity down to a cell density of 400-700 cells/mm
2
 in man (Bourne 
and Kaufman, 1976). Therefore, a cell loss of 27%, resulting in a cell density of 
1522cells/mm
2
, would be adequate for the essential pump mechanism to suffice. More 
apparent oedema may occur when the cell count is further reduced, perhaps beyond the 10-
month stage where the density is still 1240 cells/mm
2
 in the Col8a2
Q455K/Q455K
 mutant (Jun et 
al, 2012). Several studies have found an increased pump site density of the Na
+
K
+
ATPase 
suggesting that the endothelium is capable of adapting to the decrease in cell number and can 
upregulate the pumping mechanism (Geroski et al, 1985). Studies determining the effect of 
guttae on permeability of the endothelium found no change between patients with mild and 
advanced guttae (Wilson and Bourne, 1988) suggesting that perhaps decreased pump function 
is responsible for oedematous stroma typically seen in FECD. Further evidence supporting 
this theory was reported by Zhang (2006) whose study included an individual with no corneal 
guttae but very few endothelial cells.  It may simply be that eventually, even if upregulation 
of pump sites does occur, there is an insufficient number of cells to maintain stromal 
deturgescence. In later stages of FECD, when endothelial cells are reduced and Descemet’s 
membrane is thickened, the number of cells will not be sufficient to pump enough fluid 
through the thicker membrane. Endothelial cell death probably occurs due to the thickened, 
abnormal Descemet’s membrane. A thickened Descemet’s membrane would impede the 
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movement of solutes through the membrane, imposing a damaging amount of stress on the 
endothelium (Zhang et al, 2006).  
 
Biosynthesis of collagens into their triple helices is undertaken in the RER. The UPR is a 
system whose role is to reduce misfolded protein accumulation and to restore the correct level 
of folded protein. If this cannot be completed, UPR-associated apoptosis occurs. The mutant 
strains, Col8a2
Q455K/Q455K 
and Col8a2
L450W/L450W
, both had high levels of dilated RER (Figure 
4.10). Dilated RER is generally a sign of high protein synthesis and storage, but may also be 
a sign of UPR. Upregulation of collagen type VIII within the endothelium could result in 
higher volumes of collagen needing to be assembled within the ER, instigating RER dilation 
(Jun et al, 2012). Equally, increased abnormal collagen due to the Col8a2 mutation may give 
rise to dilated RER, indicative of the UPR. Other studies suggest endothelial cells may be 
transforming into a fibroblastic type cell, dilated RER and increased ribosome's being one 
possible indication of this change. Whether or not RER dilation occurs as a result of 
endothelial cell transformation, abnormal collagen type VIII, its upregulation, or something 
unforeseen, the mutation is affecting this organelle. One hypothesis is that the amino acid 
substitutions reduce the turnover of Col8a2 leading to abnormal accumulation of collagen 
VIII and subsequently, disruptions in Descemet’s membrane. The altered Descemet’s 
membrane will eventually lead to injurious effect on endothelial cells leading to apoptosis. 
  
4.2.3.3 Proteoglycan Labelling 
 
Cuprolinic-blue stained samples were also examined to determine differences in the 
proteoglycan distribution in the wild type and mutant mice. Noticeable differences in 
proteoglycan distribution were observed at the Descemet’s endothelial interface in the 
Col8a2
Q455K/Q455K 
mutant when compared to wild type. Increased proteoglycans were present 
at this interface in the mutants compared with wild type, including after enzyme digestion 
with keratanase and chondroitinase ABC. This result may indicate the remaining 
proteoglycan is heparan sulphate, a proteoglycan that has been localised to the Descemet’s 
endothelial interface previously (Bairaktaris et al, 1998). Studies have shown that heparan 
sulphate is increased at the Descemet’s endothelial interface in migrating endothelial cells 
(Davies et al, 1999). This finding may imply individual endothelial cells are migrating, a 
feature undertaken when cell death occurs to compensate for cell loss in this monolayer 
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(Svedbergh and Bill, 1972; Laing et al, 1976; Murphy et al, 1984; Landshman et al, 1988). 
Future work should label heparan sulphate in the cornea to verify this hypothesis. There are 
limitations with aspects of the analysis as the analysis is primarily observatory which may 
introduce bias. However, many of the observations made in this study are backed by recent 
publications with the collaborators. These included activation of the UPR assessed by 
western blot analysis and real-time PCR, thus, supporting the dilated RER observation in the 
Col8a2 mutants as well as other markers including TUNEL signifying apoptosis correlating 
with specular micrographs (Jun et al 2012, Meng et al, 2013). In conclusion cell death is 
occurring as a result of the mutation, however, the rate of loss is not high enough at this stage 
to jeopardise stromal hydration.  
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5. 
5.1 Introduction  
 
Human endothelial cells do not proliferate sufficiently in vivo and although there are enough 
to last a lifetime, disease, trauma and infection can result in severely reduced numbers, 
compromising corneal transparency. Endothelial cells are arrested in the G1-phase of the cell 
cycle (Joyce et al, 2002). This is illustrated in various endothelial dystrophies, where the cells 
do not replicate to replace cell loss, consequently stromal oedema results. FECD, the focus of 
the previous chapter, is a prominent disease of the corneal endothelium. This chapter 
addresses the recent advancements in correcting the loss of corneal endothelial cells by 
replacement and regeneration.  
 
5.1.1 Posterior Corneal Surgery  
 
Until recently almost all endothelial related problems have resulted in corneal transplants 
involving replacement of the full cornea. Penetrating keratoplasty (PK) has proven very 
popular and successful in most patients suffering from corneal related vision loss, however, 
this surgery does carry complications including induced astigmatism and prolonged visual 
recovery. Numerous other surgeries are now in practice (Table 5.1) including posterior 
lamellar keratoplasty (PLK), pioneered by Melles (Melles et al, 1998). Benefits include faster 
recovery, reduced astigmatism and maintenance of globe integrity, overcoming some of the 
weaknesses existing in PK (Melles et al, 2000; Gorovoy, 2006; Price & Price, 2007). PLK 
dissects the recipient stroma at 80-90% of its depth also including Descemet’s membrane and 
the endothelial layer before replacing with donor stroma, Descemet’s membrane and 
endothelium via a 9.0mm scleral incision (Melles et al, 1998, 1999; Terry and Ousley, 2001). 
Recent procedures fold donor tissue so a decreased incision of 5.0mm can be made (Melles et 
al, 2002). PLK is now referred to as DLEK, the same technique using modified instruments 
(Terry and Ousley, 2003).  
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5.1.1.1 DSEK/DSAEK 
 
DLEK led to a technique named descemetorhexis involving Descemet’s membrane removal 
from the recipient cornea leaving the stroma fully intact (Melles et al, 2004). This method, 
later named DSEK (Price and Price, 2005), is quicker and less traumatic than PLK. The use 
of a microkeratome in this procedure was used to increase precision and smoothness of the 
graft-host interface (Gorovoy, 2006), a technique now known as DSAEK. DSAEK surgery 
involves the removal of Descemet’s membrane (Melles et al, 2004) and endothelium from the 
recipient cornea and replacing with donor stroma, Descemet’s membrane and endothelium 
(Price and Price, 2006, Gorovoy, 2006). DSAEK is favoured by many corneal surgeons for 
correcting endothelial related complications.  
 
5.1.1.2 nDSAEK  
 
nDSAEK uses a similar method to DSAEK (Figure 5.1) but leaves the host cornea fully intact 
(Kobayashi et al, 2008). It was introduced for the treatment of endothelial dysfunction not 
associated with guttae. DSAEK surgery will be necessary for diseased endothelial cells, 
Table 5.1 Advancements in posterior corneal surgery over the last decade. Manual dissection and larger 
incisions originally used in PLK have been replaced by automated dissection and small incisions leading to 
the development of DSAEK. The nDSAEK procedure evolved from DSAEK, involving the same tissue 
transplantation but without graft dissection. 
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however, in non-FECD type endothelial dysfunction DSAEK surgery could be replaced by 
nDSAEK, eliminating the need for Descemet’s membrane stripping (Kobayashi et al, 2008). 
Kobayashi has shown positive results for this surgery with superior visual acuity and little 
induced astigmatism. It also diminishes the need to remove Descemet’s membrane resulting 
in a simpler procedure. Nevertheless, nDSAEK does carry complications including graft 
dislocation after surgery (Kobayashi et al, 2008). Questions also remain as to the fate of the 
sandwiched endothelial cells of the host cornea.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.1.2 Rho-Associated Kinase Inhibitors 
 
As well as corneal surgery there are now studies investigating implantation of cultured 
endothelial sheets, overcoming the problem of donor tissue shortage (Ishino et al, 2004; 
Koizumi et al, 2007). These studies have reported promising results for this technique, 
Figure 5.1 Methods used in DSAEK and nDSAEK surgery. DSAEK surgery-Descemet’s membrane 
stripped from host. Posterior donor cornea trimmed (posterior stroma, Descemet’s membrane and 
endothelium). Posterior donor cornea transplanted onto posterior host cornea resulting in DSAEK cornea. 
nDSAEK surgery-Posterior donor cornea transplanted onto posterior surface of full host cornea to achieve 
nDSAEK cornea. nDSAEK cornea represented in inset schematic (adapted from Masaki et al, 2012). 
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including typical endothelial morphology and function. The addition of pharmacological 
agents has also meant that the proliferative ability of the cells can be increased (Koizumi et 
al, 2007).  
 
A new, non-surgical treatment is now under investigation whose application is based on the 
Rho-Rho kinase pathway. The Rho family of guanosine triphosphatases (GTPases), including 
Rho, Rac, and Cdc42, control many intracellular processes and cytoskeleton functions. Rho 
was first described in the early 1990s as a new member of the Ras family responsible for the 
assembly of contractile actin-myosin filaments in Swiss 3T3 fibroblasts (Ridley and Hall, 
1992). GDP-Rho (inactive) is converted to GTP-Rho (active) by extracellular signals, 
effectively acting as a molecular switch to control signal transduction pathways. Recently, 
many Rho effector molecules have been identified including Rho-associated kinase (ROCK). 
ROCK belongs to the serine/threonine family of kinases consisting of an amino terminal 
domain, a central coiled region, and a carboxyl terminus. It is involved in the cytoskeleton 
function, actin-myosin mediated contraction, cell cycle progression and apoptosis. For 
example, ROCK can phosphorylate the myosin light chain (MLC) and inactivate myosin 
phosphatase; this enables it to regulate MLC phosphorylation, responsible for smooth muscle 
contraction (Amano et al, 1996). The amino terminus hosts the kinase, whilst the carboxyl 
terminus consists of the Rho-binding domain and a pleckstrin homology (PH) domain (Figure 
5.2). ROCK is retained in its inactive state by an autoinhibitory loop whereby the PH and 
Rho binding domain bind to the amino terminal. Activated Rho can bind to the Rho-binding 
domain of ROCK which allows an open conformation of the kinase, thus, activating the 
kinase activity of ROCK. From here, ROCK can increase contraction, migration and 
proliferation.  
 
 
 
 
 
 
 
 
 
   
ROCK I 
Kinase RBD P
Coiled-coil region 
A 
B 
Figure 5.2 ROCK I. A) ROCK is composed of an amino terminus, coiled-coil region and a carboxyl 
terminus. B) Autoinhibitory loop formed to inactivate ROCK. RBD-Rho-binding domain, PH-Pleckstrin 
homology. 
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Rho GTPases are known to play an important role in cell cycle progression. There have been 
numerous studies reporting that Rho inactivation results in blockade of the G1-S phase 
progression. This blockade of progression has been reported in Swiss 3T3 fibroblasts (Olson 
et al, 1995) together with blockade of cell cycle proteins in the hearts of cardiomyocytes 
(Zhao and Rivkees, 2003). ROCK inhibition is thought to decrease certain cyclins and cyclin 
dependent kinases which are important in the cell cycle, hence, their ability to cause 
disruption in cell cycle progression. However, a recent study has found the opposite, 
reporting that inhibition of ROCK promotes proliferation and cell migration whilst 
decreasing apoptosis in monkey corneal endothelial cells (MCECs) (Okumura et al, 2009). 
Anti-apoptotic effects have been reported not only in MCECs but also in studies in spinal 
cord injury (Dubreuil et al, 2003) and dissociated human embryonic stem cells (Wantanabe et 
al, 2007). Y-27632 is widely used as a specific ROCK inhibitor (Uehata et al, 1997) able to 
compete with ATP for binding to the kinases. Reported findings could have a huge impact on 
the regeneration of corneal endothelial cells which have been depleted in surgery, trauma, 
and endotheliopathies. It would also be beneficial in corneal transplatation, preserving 
endothelial cells during transport of tissue for surgery.  
 
The main aims of this study were to better understand the effects of  
i) posterior corneal surgery and the changes that occur to the endothelial cells within 
the cornea  
ii) ROCK inhibitor, Y-27632, on endothelial cells.  
 
5.2 Material and Methods 
 
5.2.1 Posterior Corneal Surgery 
 
Tissue used in this study was obtained from Dr Hiroki Hatanaka (Kyoto Prefectural 
University of Medicine, Kyoto, Japan) who performed the experimental nDSAEK surgery. 
Eyes were allowed to heal for two weeks post-surgery before being studied (n=3). 
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5.2.1.1 Graft Tissue Preparation 
 
Donor lenticules from Japanese white rabbits (female, 2-3kg body weight, Shimizu 
Laboratory Supplies Co., Ltd, Kyoto, Japan) were obtained after death by injection with 
pentobarbital sodium. Corneo-scleral buttons, 100-200µm thick, 8.0mm in diameter, were 
dissected manually before unilateral transplantation into the graft tissue. Recipient rabbits 
were anesthetised (ketamine hydrochloride, xylazine and tropical oxybuprocaine) prior to the 
surgery using the procedure carried out by Price (Price and Price, 2005). 
  
5.2.1.2 DSAEK/nDSAEK 
 
DSAEK surgery involved the creation of a 3.0mm limbal-corneal incision prior to 
Descemet’s membrane stripping of an area measuring 9.0mm in diameter. The graft tissue 
was inserted into a Busin glide (endothelium facing anterior chamber) before being pulled 
into place with forceps. An air bubble was used to aid graft to recipient attachment before 
stitching the incision. Descemet’s membrane was not scraped in nDSAEK surgery (see 
Hatanaka et al 2012 for full details). Several ultra-thin sections from limbus, central and 
peripheral regions of the cornea were collected on each grid and examined to determine key 
alterations in the tissue n=3. 
 
5.2.2 Rho-Associated Kinase Inhibitor  
  
A pair of corneas from the same human donor were obtained, one stored in Optisol, the other 
stored in Optisol with ROCK inhibitor, Y-27632. TEM was used to examine the effect of Y-
27632 on the morphology of the treated and untreated endothelial cells. The second part of 
the study involved TEM examination of rabbit corneas injected with differing endothelial cell 
densities prior to treatment with Y-27632 to determine the appropriate density required for 
complete monolayer regeneration.  
  5.2.2.1 Corneal Storage with ROCK Inhibitor 
 
Human corneas stored in Optisol with ROCK inhibitor, Y-27632 (10µm), had specific 
inclusion and exclusion criteria to ensure any differences observed were related to the ROCK 
inhibitor. These included: 
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 A pair of corneas from the same individual  
 No endothelial disease or severe epithelial damage 
 No less than 2000cells/mm2 of endothelial cells 
 No more than 12 hours between death and preservation in Optisol 
 No more than 300cells/mm2 difference between left and right cornea.  
 
One cornea was placed into Optisol (n=4), the other into Optisol with Y-27632 (n=4) before 
being processed for TEM. Microscopy was carried out to determine differences between 
control and ROCK inhibited endothelial cells. Several sections were cut for each sample in 
different regions of the block to ensure all areas were analysed.   
 
5.2.2.2 Endothelial Cell Injection with Y-27632 in vivo 
 
The second part of the study injected different concentrations of rabbit endothelial cells 
(2x10
5
, 5x10
5
 and 1x10
6 
cells) into rabbit cornea in vivo to find the number of cells required 
for monolayer assembly with Y-27632 (10µm).  
 
 5.2.3 TEM 
 
Tissue was fixed for 3 hours in 2.5% glutaraldehyde and 2% paraformaldehyde in appropriate 
buffers for 2-3 hours. TEM processing was carried out as described in the general methods. 
Semi (500 nm) and ultra-thin (100 nm) sections were cut and collected on glass slides or 
uncoated copper grids, respectively, prior to staining with uranyl acetate and Reynolds lead 
citrate for 12 and 5 min, respectively. Toluidine blue (1%) was used to stain semi-thin 
sections used for light microscopy.  
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5.3 Results 
 
5.3.1 Posterior Corneal Surgery 
 
5.3.1.1 Low Magnification Graft-Host Interface 
 
Figure 5.3 shows light micrographs of DSAEK and nDSAEK corneas two weeks after 
surgery. The boundary between the donor and host tissue can be seen in both micrographs, 
these are shown by black arrowheads. The interface is less predominant in DSAEK surgery 
as there is a stroma-stroma interface as opposed to a stroma-endothelium interface in 
nDSAEK. The interface stands out as a result of the host endothelial cells and Descemet’s 
membrane positioned in the posterior third of the nDSAEK cornea. One thing that is common 
in both micrographs is the good adherence in both surgeries. There does not appear to be any 
dissociation between the two tissues. 
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Figure 5.3 Toluidine blue (1%) stained light micrographs taken from resin embedded semi-thin 
sections of control, nDSAEK and DSAEK corneas 14 days post-surgery. Graft-host interface is 
indicated by arrowheads in nDSAEK and DSAEK. Clear retention of Descemet’s membrane is observed in 
nDSAEK cornea, sandwiched between host and graft stroma. Scale bar= 50 m.  
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5.3.1.2 TEM 
 
Figure 5.4 shows TEM images of the endothelial cells on the posterior of the cornea in 
control, nDSAEK and DSAEK rabbit tissue. Cell morphology of nDSAEK and DSAEK 
tissue was comparable to control.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Transmission electron micrographs of posterior endothelial cell layer. (A) Control (B) nDSAEK 
(C) DSAEK. Organelles are highlighted, mitochondria (arrowheads), nucleus (*), rough endoplasmic reticulum 
(arrows), DM-Descemet’s membrane. Scale bars=200 nm.  
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TEM examination of nDSAEK and DSAEK corneas revealed very different interfaces. This 
was primarily due to the sandwiched host endothelial cells present in the nDSAEK cornea 
compared to a stroma-stroma interface in DSAEK tissue. 
 
Micrographs from the nDSAEK cornea indicate the host endothelial layer becomes 
incomplete two weeks post-surgery (Figure 5.5). The cells appear to degenerate at various 
points in the monolayer leaving gaps which are only visible by TEM. A fibrous material 
appears between these cells, although it is uncertain what this material is, a possible source 
may be the host endothelial cells. We speculate that the fibrotic-like tissue represents the 
early stages of cellular transformation. Duplication of a basement membrane on the host 
endothelial posterior surface was the final feature of this tissue. This resulted in cells having a 
membrane on both its apical and basal surface.  
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Figure 5.5 TEM micrographs from nDSAEK tissue two weeks post-surgery. (A) Fibrotic material 
between host endothelial cells (*). (B) Duplication of Descemet’s membrane (arrowhead). (C) Incomplete host 
endothelium and fibrous tissue (*) between endothelial cells and Descemet’s membrane. HE-host 
endothelium, DM-Descemet’s membrane, GS-graft stroma, ◊-nucleus. Scale bars=1 µm.  
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Although the interface in DSAEK tissue was less distinct in the light micrographs it was still 
present. The interface was located due to the presence of a thin layer of fibrous-like material 
in the posterior third of the cornea (Figure 5.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6 Micrographs of the DSAEK interface. Scar/fibrotic tissue (arrowheads) is clearly visible 
between host (HS) and graft (GS) stroma (A). This region was imaged at higher magnifications (B) showing 
disorganised tissue noticeably different from typical stroma. Scale bars=1 µm.  
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5.3.2 ROCK Inhibitor (Y-27632) 
 
5.3.2.1 Human Corneal Storage with Y-27632 
 
Both peripheral and central regions of endothelium in human corneas were examined in 
control and Y-27632 treated tissue to determine the effects of the ROCK inhibitor (n=4). No 
obvious differences were observed between the groups, both layers looked healthy and 
organelles appeared unchanged (Figure 5.7).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.3.2.2 Endothelial Cell Injection with Y-27632 
 
Three different densities of endothelial cells were injected into rabbits with removed 
endothelium to determine the number of cells required to reproduce the monolayer with Y-
27632. Cell numbers were calculated to determine a density of 5.0x10
5
 cells was required for 
monolayer regeneration (Research Center for Regenerative Medicine, Doshisha University, 
Kyoto, Japan). TEM was carried out to examine individual endothelial cells at each of the 
cell injection densities (2.0x10
5
, 5.0x10
5
 and 1.0x10
6
 cells). Figure 5.8 shows micrographs of 
the stroma and endothelium of injected rabbit corneas. The lowest density of injected 
endothelial cells had an oedematous stroma anterior to a thinned endothelial cell monolayer. 
The stroma of corneas injected with 5.0x10
5
 and 1.0x10
6
 cells appeared normal with 
Figure 5.7 Y-27632 treated and un-treated peripheral and central endothelial cells. Morphology of the 
endothelial cells were comparable to control cornea. Scale bar=0.5 µm 
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regularly arranged fibrils within the stroma and a healthy endothelial monolayer. TEM 
analysis confirms that an injection of 5.0x10
5
 cells appears to be adequate for endothelial 
monolayer renewal whereas the introduction of 2.0x10
5
 cells results in areas of oedema 
within the stroma possibly due to insufficient endothelial cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 Micrographs of rabbit stroma and endothelium with different injected cell numbers. A cell 
density of 2.0x10
5
 cells resulted in an oedematous stroma (squared) with thinned endothelial cells. Higher cell 
densities (5x10
5
 and 1x10
6
 cells) resulted in regularly arranged collagen fibrils and endothelial cells 
resembling typical morphological structure. Scale bars-endothelium=1 µm, stroma=500 nm. 
Figure 5.9 Micrographs representing control corneas devoid of cell injection with Y-27632. Scale 
bars=500 µm, stroma=500 µm.  
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5.4 Discussion 
 
5.4.1 Posterior Corneal Surgery 
 
nDSAEK surgery is now being used in patients with encouraging results. Nevertheless, there 
is still little known about the host endothelial cells and Descemet’s membrane sandwiched 
between the host and graft stroma. Kobayashi and colleagues have reported that some 
patients suffer from donor dislocation post nDSAEK surgery (Kobayashi et al, 2008) and 
perhaps the reason stems from the presence of remaining host Descemet’s membrane and 
endothelial cells. This study was carried out to determine the structural integrity of the host 
endothelial cells, Descemet’s membrane, and how well the graft adheres to the host tissue in 
rabbit. The stroma was also investigated to see if the surgery had altered its architecture. Both 
TEM and light microscopy were used to determine the effects on the tissue which had 
undergone nDSAEK surgery two weeks prior. 
 
Together with TEM, light micrographs show that host endothelial cells and Descemet’s 
membrane are still present two weeks after nDSAEK surgery. Light micrographs showed a 
well adhered graft with a thin, distinct interface where the host endothelium meets graft 
stroma. Electron micrographs support this result as clear endothelium and Descemet’s 
membrane are visible in the posterior third of the cornea. These cells stained positively for 
Na
+
K
+
 ATPase (Figure 5.10), a protein involved in the endothelial pumping system 
suggesting that they have retained some of their functionality (Hatanaka et al, 2012). This 
activity, however, does not seem to affect the visual acuity of patients (Kobayashi et al, 
2008). If the Na
+
K
+
ATPase is still functional in the host endothelial cells then there is a 
possibility that a dual bicarbonate pump is functioning within the same cornea. There does 
not appear to be any reason why these trapped cells would not function and move fluid out of 
the host stroma into the graft resulting in a more hydrated graft stroma. However, Hodson 
carried out a series of experiments that challenges this theory. His results showed that when 
the fluid (i.e. aqueous humor) is removed from the endothelium’s apical surface, the pump 
ceased (personal communication). This related to the build-up of lactic acid around the 
endothelium, an occurrence which would likely transpire in nDSAEK surgery if the pump 
persisted. Thus, based on this finding it is unlikely that these sandwiched cells retain any 
pump functionality.   
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As previously discussed, host endothelial cells are present at the interface two weeks post-
surgery in nDSAEK, however, at this time-point the host endothelial layer is incomplete and 
what appears to be a fibrotic tissue is being deposited. The composition of this material is not 
known but it may be produced by the host endothelial layer in response to the graft tissue on 
its posterior surface. TEM also shows endothelial cell extensions into the graft stroma. 
Endothelial cell extensions, together with the fibrotic material observed at the interface 
implies that the endothelial cells are transforming. The cells may be under stress resulting in 
phagocytic activity and possibly migration into the stroma. Duplication of Descemet’s 
membrane on the apical surface of endothelial cells is also observed (Figure5.5B). Type IV 
collagen is deposited by the corneal endothelium on its distal surface, it may be that it is also 
deposited on its proximal surface but under normal conditions is removed by the aqueous 
humour that bathes the cells. The absence of aqueous humour posterior to the sandwiched 
endothelial cells may result in the duplication of Descemet’s membrane. The presence of 
endothelial cells, the unidentified fibrous tissue and what appears to be duplication of 
Descemet’s membrane may have an effect on graft adherence, however, dislocation of the 
graft was not seen in these studies. Nevertheless, this surgery is still in its early stages and 
Figure 5.10 Na
+
K
+
ATPase expression in DSAEK and nDSAEK tissue 14 days post-surgery. Host 
(arrowheads) and graft (arrows) corneal endothelial cells expressed Na
+
K
+
ATPase in nDSAEK surgery, DAPI 
(blue) nuclear stain highlights a discontinuous line at the graft-host interface (arrows). Na
+
K
+
ATPase 
expression (green) also present in graft endothelial cells in DSAEK tissue. Scale bar=100 µm. Taken from 
Hatanaka et al, 2012. 
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although graft detachment was not seen in our experiments it may differ in human tissue. The 
majority of patients that have undergone nDSAEK did not experience graft dislocation 
(16.7% dislocated graft, Kobayashi et al, 2008), some studies reporting no graft dissociation 
(Masaki et al, 2012). There are still many unknowns surrounding this technique, mainly the 
long-term outcomes of the surgery including the morphology and location of the host 
endothelial cells. 
 
Studies using confocal and slit lamp images have reported normal epithelial cells and 
keratocytes but also observed particles present at the graft-donor interface (Kobayashi et al, 
2009). Kobayashi found that nDSAEK graft-recipient interface particles were larger than 
those observed in DSAEK. He concluded that either Descemet’s membrane or the 
compressed necrotic endothelial cells are responsible for this (Kobayashi et al, 2009). Based 
on our TEM analysis, I would agree with this conclusion as we were still able to image the 
host endothelial layer. Kobayashi’s study was carried out 3 months after surgery suggesting 
that the cells are still present at the time point or that the unidentified tissue we observed 
(scar, or new Descemet’s produced by endothelium) is responsible. Perhaps then, up to at 
least 3-months post-nDSAEK surgery, remnants of the endothelial layer or Descemet’s 
membrane are still visible at the interface but are dispersing as shown by the reduced 
interface haze in Kobayashi’s study (Kobayashi et al, 2009). 
 
nDSAEK surgery could be useful in non-FECD type endothelial dysfunction where the 
endothelial layer is not pathogenic. It may also be beneficial in eyes without lens or iris 
which become challenging in DSEK surgeries. Fragments of Descemet’s membrane from the 
donor cornea can drop down during DSEK surgery which interferes with retinal function if 
there is no barrier between the anterior and posterior eye, i.e. lens. When Descemet’s 
membrane is not stripped this problem is avoided (Price et al, 2007). This surgery can also be 
carried out for failed PKs, the original purpose for this surgery was to correct endothelial 
dysfunction after failed PK. Descemet’s membrane and Bowman’s membrane are thought to 
adhere most strongly after PK surgery. In failed PKs, where the endothelial cell count is low, 
nDSAEK may be beneficial.  
 
DSAEK surgery has become increasingly popular over recent years after the initial success of 
posterior lamellar keratoplasty by Melles and colleagues (Melles et al, 1998). These 
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procedures have progressed rapidly as more advanced instruments, including the 
microkeratome and Busin glide, have been developed allowing more precise donor button 
cutting and smaller initial recipient incision. Results from this study support the positive 
results surrounding DSAEK surgery. Slit lamp imaging demonstrates that corneas become 
clear one week post-surgery (Hatanaka et al, 2012) with well adhered graft demonstrated by 
light microscopy (Figure 5.3). The difficulty in finding the interface by both TEM and light 
microscopy is likely to signify good graft adherence. It is already known that the stroma-
stroma interface provides good adhesion, with lower graft detachment rates than those seen in 
nDSAEK (Price and Price, 2005; Price et al, 2010). It is thought that DSAEK surgery is 
much like laser-assisted in situ keratomileusis (LASIK) in that both result in a stroma-stroma 
interface. LASIK is an effective surgical procedure for correcting refractive errors and has 
rare cases of flap displacement (Lin and Maloney, 1999). Tissue stained positively for 
Na
+
K
+
ATPase (Figure 5.9), a sign that the graft endothelial cells are functional. As 
previously mentioned, the interface was difficult to find especially by TEM examination. 
When located, it appeared as a zone of granular tissue at the junction between the host and 
graft stroma. In-vivo confocal studies have reported interface haze and high levels of interface 
particle density post DSEAK surgery. These levels decrease during the 6-month study period, 
nevertheless, levels are higher than those observed in nDSAEK at every time-point. The 
material we observe with TEM may be responsible for this haze, just at a later stage. This 
material will probably have an effect on visual acuity, which in Kobayashi’s DSAEK study 
could be why the majority of patients did not reach 20/20 or better (Kobayashi et al, 2008). 
The presence of granular material suggests that even a stroma-stroma interface can cause 
interface haze. 
 
DSAEK techniques have evolved further and now include ultra-thin DSAEK, a procedure 
where the donor button comprises of endothelium, Descemet’s membrane and an ultra-thin 
layer of stroma (approx. 100 µm). Ultra-thin DSAEK achieves similar visual results to those 
reported in DMEK without the difficult donor preparation (Busin et al, 2012). DMEK surgery 
is also available, however, preparation of the thin donor tissue is challenging, resulting in 
high numbers of lost grafts, increased graft detachment, increased donor preparation time and 
unfolding challenges (McCauley et al, 2009). These are just a few examples of how DSAEK 
surgery has, and is still advancing to overcome some of the complications that have emerged. 
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The stroma-stroma interface formed in DSAEK has better adherence compared with stroma-
endothelium interface present in nDSAEK. This is demonstrated well by the increased graft 
dissociation in nDSAEK surgery (Kobayashi et al, 2008). Although nDSAEK surgery will 
not replace DSAEK it is a good alternative that avoids Descemet’s membrane stripping in 
cases with no endothelial guttae, opacities or other endothelial abnormalities. This two week 
post-operative study has provided evidence that graft tissue adheres well in nDSAEK. An 
incomplete endothelial layer resides at the interface with fibrous stroma-like tissue and what 
appears to be duplication of Descemet’s membrane on the host endothelial apical membrane. 
The fate of the host endothelial cells is yet to be determined, however, it seems that they will 
eventually become absent. These results identify the ultrastructural changes occurring after 
DSAEK and nDSAEK surgery that may provide a clue as to why certain grafts take longer to 
achieve good visual acuity than others. It also demonstrates the changes that occur in the host 
endothelial cells in the period following nDSAEK surgery, a factor that is not yet fully 
understood. 
5.4.2 The Effect of ROCK Inhibitor on Corneal Endothelial Cells 
 
Endothelial cell death is a common problem encountered in all corneal surgery, corneal 
transportation, disease and trauma. Disruption of this cell layer results in stromal swelling as 
endothelial cells are unable to pump adequate fluid out of the stroma. Due to the delicate 
nature of this cell layer, damage can occur very easily, one study found a cell loss of 33.6% 
one year after PK (Culbertson et al, 1982). Migration and enlargement of endothelial cells 
occurs after cell loss due to the limited proliferative capabilities of corneal endothelial cells. 
Corneal endothelial cells are known to be arrested in the G1-phase of the cell cycle (Joyce et 
al, 2002), a quality that, in certain circumstances, can jeopardise corneal transparency. If 
there are insufficient cell numbers to remove excess stromal fluid, the cornea becomes 
oedematous. Good storage conditions have become an important part of corneal 
transplantation and over the past two decades have been developed in an attempt to optimise 
corneal storage environment. Optisol, the main storage media used today, has proved to be 
effective in maintaining the cornea in a sufficient state for transplantation, however, there is 
still significant endothelial cell death (Means et al, 1995). Recent studies examining 
endothelial cell death, proliferation and adhesion after the addition of a ROCK inhibitor have 
shown interesting results that may be beneficial in future endothelial treatment. Early results 
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from corneal treatment with ROCK inhibitor Y-27632 have been encouraging, decreasing 
apoptosis (12.4%±4.6% in control versus 2.0%±1.6% in Y-27632 treated, annexin-V positive 
cells) whilst promoting proliferation (Ki67 expression and Brd-U labelling) and cell 
migration (Okumura et al, 2009). Overall the number of viable cultivated monkey corneal 
endothelial cells was enhanced with larger cell colonies in the Y-27632  treated group when 
compared to control. This treatment could be very beneficial in corneal transport before 
transplantation and as a pharmaceutical agent post-surgery to reduce cell death and to 
possibly increase proliferation. 
 
Whilst immunohistochemistry has been undertaken to determine the number of proliferating 
and apoptotic cells, the general morphology of the cells and state of the stroma is still 
unknown. This study provides additional data supporting Y-27632 as an effective agent in 
endothelial cell health with TEM analysis. The morphology of the Y-27632 treated cells was 
comparable to the controls with typical organelles. Okumura’s study (Okumura et al, 2009) 
reported a decrease in the number of cells undergoing apoptosis. TEM analysis did not reveal 
any necrotic or abnormal cell morphology in the treated group. Cell structure and organelles 
appeared normal in all sections and regions through corneal depth imaged with no signs of 
cell degradation or duplication of the endothelial cell monolayer. This data is reassuring and 
based on the morphological analysis the drug treatment does not appear to have any negative 
effects. Okumura’s study on Y-27632 primate treated cells shows increased adhesion of cells 
in culture (Okumura et al, 2009); it is possible that suppression of migration leads to 
increased adhesion.  
 
The second study used rabbit cornea to determine the number of endothelial cells required for 
complete monolayer regeneration and to give an insight into how these cells behave post 
injection in vivo. Three different cell volumes were injected. The lowest density (2x10
5
 cells) 
resulted in an oedematous posterior stroma, an outcome probably due to a lack of cells to 
counteract the fluid leaking into the stroma via the pump mechanism. The endothelial cells in 
these micrographs also appeared thinner and stretched, possibly due to excessive cell 
spreading to compensate for the inadequate number of cells overall. Organelles were sparse 
with not nearly the same volumes as we would normally expect to see in these cells, a 
possible sign that these cells are stressed and cannot sustain typical cell functions and the 
maintenance of organelles. This was not the case in the corneas injected with the higher cell 
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densities. There was no evidence of stromal oedema in these rabbits, endothelial cells looked 
normal with characteristic organelles. These findings helped to establish that a density of 
5x10
5
 cells was adequate to form a sufficient cell monolayer, capable of maintaining stromal 
deturgescence. These data also show a clear suggesting that the cell volume injected does not 
cause duplication of the cells; an outcome that could jeopardise the pumping mechanism and 
therefore stromal hydration and transparency.  
 
Previous studies working on adult human corneal endothelial cells found that they retain the 
essential functions required to maintain stromal dehydration in vivo (Mimura et al, 2004), a 
quality meaning these cells would also be viable for transplantation. New techniques for 
posterior corneal surgery are frequently being developed with the general consensus that the 
thinner the graft the better the outcome (Dapena et al, 2009). However, due to the fragile 
nature of transplanting endothelial cells alone, many surgeries include stroma and Descemet’s 
membrane; a practice that could be avoided if the surgery was combined with Y-27632 
treatment. Studies on DMEK, a surgical procedure only replacing Descemet’s membrane and 
the diseased endothelium, have shown quicker and near complete visual recovery within 1-3 
months (Ham et al, 2009). Hence, DMEK is one procedure that could benefit from this 
treatment. Transport and storage of tissue before transplantation is another area where ROCK 
inhibitors could be used. Although the current methods of corneal storage, namely Optisol, 
are adequate, there is still significant cell loss as mentioned above (Means et al, 1995). The 
time between tissue removal and surgery is a period of endothelial degeneration which 
together with surgery, results in a substantial loss of cells. An agent capable of reducing 
apoptosis and increasing proliferation would help increase the viability of the cornea for 
transplantation and reduce the chance of oedema post-surgery. In the future, Y-27632 may 
serve as a topical agent for the cornea, and as a result, a less invasive therapy for endothelial 
dysfunction.  
 
There are still challenges ahead for this treatment. Establishing the number of functional 
endothelial cells is an important factor in this study. There may be an increase in the cell 
density but their functionality may not be characteristic of normal endothelial cells. Studies 
on Schlemm’s canal endothelial cells found Y-27632 decreased transendothelial electrical 
resistance, increasing the paracellular permeability thought alterations in the tight junctions 
(Kameda et al, 2012). If the same result was to occur in the endothelial cells of the cornea, 
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this could give rise to an oedematous stroma. Even if the inhibitor did have adverse side 
effects on the endothelial cells, it does not appear to change their morphology. Questions may 
also be raised about the cell injection studies, including the fate of the remaining endothelial 
cells once the monolayer has formed. The cells are thought to be removed from the aqueous 
humor, with no effect on intraocular pressure. There are no reported effects of Y-27632 on 
keratocytes, however, this factor still needs to be considered and observed in the long-term. 
They are still cell components of the cornea and may be affected by ROCK inhibition. Future 
work examining the long-term effects of this agent on the endothelial cells and the cornea as 
a whole are going to be important to determine the drug parameters. Studies will help define 
the treatment time required for sufficient endothelial regeneration and potential adverse 
effects of Y-27632. Some of this data can be analysed in vitro, whilst other areas will need in 
vivo studies and clinical trials. Clinical trials would be beneficial in establishing the outcomes 
in patients and to support integration into the clinic. 
 
This study has helped establish the number of cells required for monolayer regeneration 
without monolayer duplication post Descemet’s stripping and the morphological effects of 
the ROCK inhibitor, Y-27632. Images provide evidence that in environments with too few 
cells, stretched and thinned cells result which may reduce efficacy of the vital pump function 
discussed in chapter 3. It is important to determine how these cells behave in their new 
environment with drug intervention; this analysis has helped elucidate this and provides 
evidence that no atypical morphology was observed.  
 
Corneal endothelial replacement and regeneration offer alternatives to traditional PK which 
have reduced adverse effects and faster recovery. DSAEK and nDSAEK surgeries provide 
effective surgical procedures for the replacement of corneal endothelial cells until techniques 
involving the transplantation of endothelia cells only are perfected. ROCK inhibition, on the 
other hand, offers endothelium regeneration without the need for invasive surgery. The 
combination of the two treatments could reduce the number of failed surgeries as a result of 
low endothelial cell count. ROCK inhibition used solely will also be beneficial corneal 
transport. Both posterior corneal surgery and ROCK inhibition offer additional and possible 
alternatives for corneal endothelium correction. Although long-term outcomes are required 
for both interventions, the benefits are clear and establish both as definite contenders in 
endothelial cell correction after depletion. 
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6. 
 
The importance of the cornea’s endothelial layer is recognised in development, disease, and 
surgery, demonstrated in this thesis. The limited replicative capability of these cells in adult 
tissue (Joyce et al, 1996) reinforces the need for intervention, whether surgical or 
pharmaceutical, to increase the endothelial cell number to maintain stromal deturgescence. 
The main aim of this thesis was to better understand corneal endothelial cells in development, 
disease and intervention. It was important to determine the changes the cells undergo in each 
of these environments and to better understand how they react and their adaptability in 
circumstances where they are under stress. The findings give an insight into the morphology 
and protein expression of the developmental endothelial cells and how they might influence 
the developing stroma. The research also highlights the effects of a knock-in mutation on the 
endothelial cells and subsequently the corneal stroma, as well as recent advancements in 
endothelial replacement and regeneration via surgery and a Rho-associated kinase inhibitor, 
respectively. These interventions will be beneficial to patients who are susceptible to 
endothelial cell loss such as those diagnosed with FECD. 
 
6.1 Endothelial Development 
 
One key role of endothelial cells is to maintain correct stromal hydration in order for corneal 
transparency to prevail. This is achieved by a pumping mechanism whose role is to 
counteract the leak of fluid into the stroma through the paracellular tight junction route. 
Chapter 3 investigated the development of the endothelial cells in embryonic chick cornea. 
Observation of the cell layer at low magnification depicted a general view of the posterior 
tissue including stroma and Descemet’s membrane. Stromal density and organisation was 
seen to increase as development progressed alongside a growing Descemet’s membrane. 
Endothelial cells consisted of numerous organelles including mitochondria whose 
responsibility is to provide the energy required for pump function correlating with early 
studies on developmental tissue (Wulle, 1972). Immunolocalisation employing a rabbit anti-
Na
+
HCO3
- 
antibody revealed the presence of the NBC in all stages labelled (E10-E14). The 
importance of this cotransporter has previously been highlighted in adult tissue (Sun and 
Bonanno, 2003), and is one of the major transporters of HCO3
-
 residing on the basolateral 
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membrane. Its presence at these early stages in development suggests it may also have a role 
in embryonic stromal hydration. Studies have reported compaction and dehydration in the 
latter stages of development, this helps increase the transparency of the cornea to 96% by E19 
(Coulombre and Coulombre, 1958). NBC, labelled at this time point, may influence this 
compaction and onset of transparency. A study carried out by Conrad et al (2006) measured 
NBC gene expression in the embryonic chick, finding that its expression increased through 
development and into the post-hatching period. These studies correlate with Conrad’s data 
and helps reinforce the concept that the cotransporter plays a role in development as well 
adulthood. The final experiment undertaken in chapter 3 used A-scan ultrasonography to 
determine the changes in thickness during the E9-E18 developmental period. This technique 
avoided the need for tissue fixation and dehydration, measuring the corneal thickness in fresh 
tissue. Alterations in the methodology led to a final experiment measuring fresh corneal 
tissue on one day in one eye. These data revealed three key trends. The first was a thickness 
increase from E9-E12 followed by a plateau in the E12-E15 developmental period and 
finally, a decrease in thickness till E18 where the final measurement was taken. Early studies 
(Hay and Revel, 1969) on cornea suggest the initial increase occurs due to primary stromal 
swelling in preparation for mesenchymal cell invasion, along with the corneal keratocytes 
populating the matrix, forming the secondary stroma. The plateau observed between E12-E15 
may be a period of stromal reorganisation before final dehydration and compaction of the 
collagen fibrils. This relates to a study measuring interfibrillar Bragg spacing reporting that 
two dehydration phases occur during avian corneal development. The first between E13-E14 
suggested to be as a result of water loss from non-collagenous regions, the second between 
E16-E17, thought to be due to a decrease in interfibrillar Bragg spacing (Siegler and 
Quantock, 2002). Our thickness decrease, post E15, correlates with their result reporting 
interfibrillar Bragg spacing decrease. We postulate that the endothelium is involved in water 
regulation and deturgescence at this period of development and that there may be two phases 
of endothelial pump activity.   
 
The majority of data collected in chapter 3 correlates with previous literature including NBC 
gene expression supporting our immunolocalisation data and the compaction studies carried 
out in embryonic chick correlating with our corneal thickness data. However, Hay and Revel 
reported thickness results which contradicted ours; I believe this was as a result of the tissue 
dehydration they used in their study. Now that the expression and importance of the NBC is 
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recognised, it will be important to determine when the cotransporter is not only expressed but 
is functional to define more specifically its role in corneal development.  
 
6.2 Part I-The Ultrastructure of Descemet’s membrane 
 
Descemet’s membrane is the basement membrane of the corneal endothelium providing it 
with a structural support that allows the movement of fluid through. When this membrane 
was examined long spacing structures with a periodicity of 100 nm are observed in the 
transverse section plane. These structures were still present in en face sections alongside the 
more typical polygonal lattice formations we would expect in this membrane (Sawada et al, 
1990, Shuttleworth, 1997). The collagen responsible for the polygonal structures is now 
recognised as type VIII collagen (Sawada et al, 1990) and it is likely that the elongated 
structures observed in both planes are also composed of the same type. Early studies on 
Descemet’s membrane show how a polygonal lattice represents a structural solution, solving 
the problem of resisting compression whilst maintaining a porous structure (Ninomiya et al, 
1990). Three-dimensional analysis revealed how the globular domains appear to be stacked 
directly on top of one another supporting this idea of lattice structures in Descemet’s 
membrane which stack on top of one another capable of allowing fluid through the 
membrane. The model created combines the elongated structures observed in both planes 
with the typical polygonal formations. The model demonstrates how both types of structure 
would allow Descemet’s membrane to be permeable. Occasionally interbands were visible 
within the elongated structures. After visualising en face sections it was concluded that these 
interbands are likely to be formed by the central globular domain we observe in the polygonal 
formations. Based on the polygonal structures it was proposed that the dominant bands are 
formed by stacked globular domains. This is also conceivably true for the intermediate bands 
observed in transverse sections of Descemet’s membrane, however, the less distinct banding 
is probably due to globular domains not being in the same plane as the distinct bands, thus, a 
weaker structure is imaged.  
 
Cuprolinic blue staining and three-dimensional analysis revealed the presence of 
proteoglycans associating with the internodal regions of the elongated structures we believe 
to be type VIII collagen. The binding of proteoglycans to the helical part of this collagen may 
assist in maintaining the arrangement of type VIII in either the polygonal lattice or the 
Chapter 6: Overall discussion 
 
 
 
127 
 
elongated structures observed via the collagenous regions of the molecule. These results 
support previously published literature on the structure of Descemet’s membrane with 
additional evidence on the assembly of collagen type VIII. Proteoglycan labelling in 
Descemet’s membrane has been previously reported (Bairaktaris et al, 1998; Davies et al, 
1999), however, this is the first data that shows proteoglycans associating with intermodal 
regions of type VIII collagen in Descemet’s membrane. This may imply they have a role in 
maintaining the unique structure of type VIII collagen in Descemet’s membrane. 
 
6.2 Part II-Col8a2 FECD Model 
 
Endothelial cells become compromised by trauma, surgery, infection and disease. Whilst they 
can adapt to cell loss by migration and enlargement of remaining cells, if the cell count 
becomes too low, stromal swelling will transpire. As in most diseases, early diagnosis is 
essential so that preventative treatment can be used to decrease the symptoms and inhibit 
disease onset. Due to the lack of symptoms in the early stages of FECD, the only tissue 
available for examination is from PKs where the features of the disease are most severe and 
represent the latter stages of FECD. This has meant that little is known about the early 
disease pathogenesis due to the lack of tissue available for examination. This has highlighted 
the need for disease models to identify the factors contributing to the pathogenesis and the 
time-points within the disease course where symptoms are revealed. Chapter 4 identified the 
ultrastructural changes within the stroma of Col8a2 knock-in murine mutants, a recently 
developed mouse model for early-onset FECD (Jun et al, 2012). It has been well established 
that corneal swelling and thickened Descemet’s membrane are features present in patients 
with the disease (Waring et al, 1978). Disorganised collagen VIII in Descemet’s membrane 
has led to studies based on mutations in this collagen (Biswas et al, 2001; Gottsch et al, 
2005). The symptoms presented in Col8a2 mutants in these studies mirror those seen in 
FECD, establishing them as disease targets. The more evident differences in our results were 
observed in the endothelial layer, including dilated RER and increased proteoglycans at the 
Descemet’s endothelial interface, suggesting the initial effects of the disease occur in this 
region. Dilated RER is a sign of high protein synthesis that is likely due to accumulation of 
collagen VIII in these mutants and activation of the UPR. The lack of evident oedema in the 
corneas, which would have been expected if endothelial pump function was compromised, 
was assumed to be due to the relatively young age of the mice. Recent studies on these 
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models have reported significant endothelial cell loss (Jun et al, 2012), however, this may not 
be adequate to compromise the pump leak system operating in the endothelial cells. The 
increased proteoglycans present at the Descemet’s endothelial interface in the 
Col8a2
Q455K/Q455K 
mutant are thought to be a product of the endothelial cells, visualised even 
after enzyme digestion with keratanase and chondroitinase ABC. This correlated with studies 
identifying changes in proteoglycans in wounded and normal cornea. Davies found increases 
in both CS and heparan sulphate in migrating endothelial cells (Davies et al, 1999). This may 
indicate that proteoglycans are playing a key role in the cellular processes in this disease 
model. These results demonstrate the resilience of the endothelial cell layer; even with a 
significant cell loss the remaining cells are clearly capable of maintaining stromal 
deturgescence. 
 
The results obtained in chapter 4 reinforce the Col8a2 knock-in murine mouse model as an 
important tool in determining the disease pathogenesis in FECD. Defining the features that 
occur in the disease will help better understand the sequence of events and ways to resolve 
them. The ultrastructural changes in the Col8a2 knock-in mouse models signify that similar 
studies at later time-points are required so that a more extensive representation of the effects 
of the disease can be obtained. This would help reveal the changes that occur between the 
initial and latter stages of the disease, and may help outline the detrimental effects on the 
cornea that need to be targeted. TEM at the Descemet’s endothelial interface highlighted the 
presence of proteoglycans in the Col8a2
Q455K/Q455K 
mutant. It is assumed heparan sulphate is 
the proteoglycan responsible as its presence remains after digestion with keratanase and 
chondroitinase ABC. However, due to time and tissue constraints, this proteoglycan was not 
labelled. Future work should include immunohistochemistry to identify this proteoglycan. It 
will also be beneficial to label collagen VIII in Descemet’s membrane to determine if its 
structure is altered and whether the proteoglycans observed at the interface are linked to this 
collagen.  
 
6.3 Corneal Endothelial Cell Replacement and Regeneration  
 
The prevalence of diseases such as FECD, has resulted in the development of procedures to 
replace the pathological tissue present in the cornea. The most common procedure carried out 
in corneal tissue, which is irreversibly damaged, is PK. Chapter 5 observed the ultrastructural 
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changes that occurred in partial corneal transplants which have become more favoured by 
corneal surgeons in recent years. Newer procedures aim to replace only the damaged/diseased 
areas of the cornea, reducing some of the problems that develop post PK. Developments in 
posterior corneal surgery have included smaller incisions, the use of automated equipment 
(Gorovoy, 2006) and decreasing the thickness of the donor grafts. Light microscopy of 
DSAEK and nDSAEK surgeries demonstrated that the adherence of both grafts was good. 
Investigation with TEM allowed a more detailed view of this interface in both surgeries. Host 
Descemet’s membrane and endothelial cells were still present 2 weeks post-surgery in 
nDSAEK and extended into the graft stroma along with scar tissue on the posterior surface of 
the host endothelial cells. The presence of Descemet’s membrane, endothelium and the scar 
tissue does not appear to interfere with visual acuity or the adherence of the graft tissue. 
However, the fibrotic scar tissue we report here, along with the host Descemet’s membrane 
and endothelium are likely to be responsible for graft dissociation in those reports studying 
nDSAEK (Kobayashi et al, 2008). 
 
DSAEK has become increasingly popular over the last few years after the initial success of 
PLK by Melles (Melles et el, 1998). The adherence of the graft is good; this was supported 
by the difficulty in finding the interface by TEM. This backs the low graft detachment rates 
previously reported for DSAEK surgery (Price and Price, 2005; 2010). The interface 
examined by TEM appeared as a layer of granular tissue between the graft and host stroma. 
Some studies have reported interface haze in DSAEK (Kobayashi et al, 2008) that may be 
due to this granular material and may be a key reason why some patients do not reach 20/20 
or better.  
 
Both DSAEK and nDSAEK are now being carried out in patients and have proved to be 
effective. Although nDSAEK cannot be used for FECD or in any problem where the 
endothelium is diseased, it will be beneficial in patients with low endothelial cell counts and 
those with failed PKs not associated with guttae. DSAEK can be used in those with diseased 
endothelium, as these cells are removed. This will be advantageous over PK as the current 
host tissue has good adherence, particularly at the basement membranes (Bowmans and 
Descemet’s). Removal of these structures will reduce the integrity of the cornea and disrupt 
the globe; hence, partial corneal replacement is a good advancement in this field.   
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The long term effects on the cornea post DSAEK and nDSAEK surgery is the main unknown. 
The first DSAEK study carried out in patients was in 2006, this is fairly recent and there is 
little data available on the changes within the tissue at higher magnification. Once patient 
DSAEK corneas do become available it will be important to observe the interface and 
remaining endothelial cells to determine the effects of time on the tissue. I think the most 
important feature in this surgery will be the interface, especially in nDSAEK surgery where 
the original endothelial cells reside and a scar-like tissue is present. What happens to the host 
endothelial cells and the overall state of the interface after longer durations? Partial surgeries 
have developed further and have helped pave the way to ultra-thin DSAEK and even 
replacement with only Descemet’s membrane and endothelium, although the latter has 
proven difficult due to the delicate nature of the tissue. This is the future in posterior corneal 
surgery and investigation into the ultrastructure of this tissue should also be considered.  
 
Corneal transplantation is not the only method for correcting corneal endothelial cell loss. 
Recently, studies investigating a ROCK inhibitor have shown increased proliferation, 
adhesion and decreased apoptosis in the corneal endothelium (Okumura et al, 2009). The 
second part of Chapter 5 examined the effects of the ROCK inhibitor, Y-27632, on the 
morphology of the corneal endothelium in human and rabbit samples. Results from TEM 
analysis illustrate that the endothelial cells present in the Y-27632 treated group were 
comparable to control samples in human corneas. This data correlates with previous findings 
reported by Okumura and colleagues that apoptosis is decreased in these cells after treatment 
with ROCK inhibitor (Okumura et al, 2009). The second part of the ROCK inhibitor 
investigation into corneal endothelial cells was concerned with cell injection studies. Initially, 
increasing cell volumes were injected into endothelial stripped rabbit corneas to determine 
the cell density required to form a new, complete monolayer. After discovering that a cell 
density of 2x10
5
 cells resulted in an oedematous stroma and thinned endothelial cells, a cell 
density of 5x10
5
 cells was established as an appropriate volume to be used. Together with 
previous studies, this data supports the notion that endothelial cells can be injected, and with 
the support of the ROCK inhibitor, Y-27632, are capable of regenerating the endothelial cell 
layer.  
 
The use of Y-27632 in cell injection therapies is beneficial but it is important to note that this 
ROCK inhibitor has the potential to be used in such surgeries as DSAEK/nDSAEK as well as 
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a component of storage media’s used to transport and store corneal tissue. Thus, Y-27632 is a 
promising novel therapy for the treatment of corneal endothelium dysfunction. 
 
A number of challenges lie ahead for the ROCK inhibitor studies. So far, the main research 
for Y-27632 has been based on animal models. The next logical step for this treatment is 
clinical trials to conclude whether or not the same results can be replicated in man. Treatment 
time required in patients and any long term effects on the ocular tissue are other parameters 
that need to be determined. Increased intraocular pressure and the abnormal deposition of 
endothelial cells on the posterior cornea have not been reported in any of the studies so far 
but should be considered in future trials (Okumura et al, 2012). 
 
6.4 Summary  
 
The techniques used to study the morphology of the corneal endothelium and the expression 
of the pump show how the cells change through development. It also demonstrates how the 
thickness of the cornea can change in a short period of time, an important process in 
development and a feature that needs to be controlled into adulthood. In addition these 
studies have also shown that disease can severely affect the cells of this monolayer by both 
attenuation and decreased cell density that consequently, affects stromal hydration. FECD is a 
primary corneal endotheliopathy responsible for many PKs. The initial pathogenesis of FECD 
is still not fully understood due to the lack of tissue available in the early disease stages. The 
production of a murine model based on knock-in mutations previously established by Biswas 
and Gottsch (Biswas et al, 2001; Gottsch et al, 2005) has allowed us to determine the early 
changes that exist in FECD corneas. The final chapter focusing on corrective 
procedures/interventions will aid endothelial cell loss. Corneal surgery has been developed as 
a direct result of these diseases, as well as infection and trauma. Recent developments in 
posterior corneal surgery have produced promising results. DSAEK and nDSAEK are 
increasingly chosen over traditional PK because of faster visual recovery and reduced 
astigmatism. Although there are changes to the corneal ultrastructure after these surgeries, 
they do not appear to affect the outcomes in patients nor do they compromise the graft. They 
are an important development in this field and have led to further developments in the form 
of ultra-thin DSAEK and DMEK. Recently, ROCK inhibition has also generated interest as a 
result of its proliferative effects on endothelial cells. The results reported here supply 
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additional evidence that this inhibitor has beneficial effects on the endothelial cells whilst not 
interfering with general cell morphology. The importance of the endothelial layer is 
highlighted in this thesis, where enough disruption will lead to stromal oedema. This has 
resulted in extensive research into replacement and regeneration of the cell layer that has a 
crucial role in maintaining stromal deturgescence, a feature vital to corneal transparency.   
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Appendix I 
      
1. Embryonic chick corneal thickness data 
 
The following tables contain the average raw data values measured in embryonic chick 
cornea for the separate experiments carried out.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corneal thickness in both eyes of embryonic chick. Table shows the average corneal thickness 
and standard deviation measured from both eyes on one day between the E9-E18 developmental 
period in embryonic chick corneas. 
Left and right corneal thickness measurements in embryonic chick cornea. Values are 
average thickness measurements and standard deviation for each embryonic day (E9-E18).  
Appendix 
154 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corneal thickness in left eye only from final experiment. Table shows average corneal thickness 
and standard deviation of thickness data measured in the left eye only between the E9-E18 
developmental period.  
Combined left corneal thickness data. Standard deviation and averaged corneal thickness data 
collected from all left corneal data.  
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Tukey-Kramer multiple comparisons test multiple comparisons test for experiment 2. 
 
                              
            Comparison             Difference    q        P value   
================================== ==================  
             E9 vs E10               -0.02047   5.172  *    P<0.05 
             E9 vs E11               -0.04395  11.487 ***  P<0.001 
             E9 vs E12               -0.08519  21.249 ***  P<0.001 
             E9 vs E13                -0.1113  28.131 ***  P<0.001 
             E9 vs E14                -0.1330  36.416 ***  P<0.001 
             E9 vs E15                -0.1077  27.204 ***  P<0.001 
             E9 vs E16               -0.08443  21.331 ***  P<0.001 
             E9 vs E17               -0.05122  13.096 ***  P<0.001 
             E9 vs E18               -0.03122   7.888 ***  P<0.001 
            E10 vs E11               -0.02347   5.602  **   P<0.01 
            E10 vs E12               -0.06471  14.849 *** P<0.001 
            E10 vs E13               -0.09088  21.077 ***  P<0.001 
            E10 vs E14                -0.1126  27.907 ***  P<0.001 
            E10 vs E15               -0.08721  20.227 ***  P<0.001 
            E10 vs E16               -0.06396  14.834 ***  P<0.001 
            E10 vs E17               -0.03074   7.203 ***  P<0.001 
            E10 vs E18               -0.01075   2.493  ns   P>0.05 
            E11 vs E12               -0.04124   9.731 *** P<0.001 
            E11 vs E13               -0.06740  16.086 ***  P<0.001 
            E11 vs E14               -0.08908  22.824 ***  P<0.001 
            E11 vs E15               -0.06374  15.211 ***  P<0.001 
            E11 vs E16               -0.04049   9.662 *** P<0.001 
            E11 vs E17              -0.007271   1.754  ns P>0.05 
            E11 vs E18                0.01272   3.036  ns   P>0.05 
            E12 vs E13               -0.02616   6.003  **   P<0.01 
            E12 vs E14               -0.04784  11.717 *** P<0.001 
            E12 vs E15               -0.02249   5.162  *    P<0.05 
            E12 vs E16              0.0007554  0.1733  ns   P>0.05 
            E12 vs E17                0.03397   7.872 ***  P<0.001 
            E12 vs E18                0.05396  12.382 ***  P<0.001 
            E13 vs E14               -0.02168   5.375  **   P<0.01 
            E13 vs E15               0.003667  0.8504  ns   P>0.05 
            E13 vs E16                0.02692   6.243 *** P<0.001 
            E13 vs E17                0.06013  14.088 ***  P<0.001 
            E13 vs E18                0.08013  18.584 ***  P<0.001 
            E14 vs E15                0.02534   6.284 ***  P<0.001 
            E14 vs E16                0.04859  12.049 ***  P<0.001 
            E14 vs E17                0.08181  20.520 ***  P<0.001 
            E14 vs E18                 0.1018  25.242 ***  P<0.001 
            E15 vs E16                0.02325   5.393  **  P<0.01 
            E15 vs E17                0.05647  13.229 ***  P<0.001 
            E15 vs E18                0.07646  17.734 *** P<0.001 
            E16 vs E17                0.03321   7.782 ***  P<0.001 
            E16 vs E18                0.05321  12.341 ***  P<0.001 
            E17 vs E18                0.01999   4.684  *    P<0.05 
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Tukey-Kramer multiple comparisons test for experiment 3. Period of thickness plateau is in bold. 
 
                                         
            Comparison             Difference    q        P value   
================================== ========== ======= =========== 
             E9 vs E10               -0.03824  16.465 ***  P<0.001 
             E9 vs E11               -0.05556  22.643 ***  P<0.001 
             E9 vs E12               -0.09554  34.892 ***  P<0.001 
             E9 vs E13               -0.09999  40.748 ***  P<0.001 
             E9 vs E14                -0.1018  39.610 ***  P<0.001 
             E9 vs E15                -0.1064  43.902 ***  P<0.001 
             E9 vs E16               -0.06764  28.090 ***  P<0.001 
             E9 vs E17               -0.05159  20.729 ***  P<0.001 
             E9 vs E18               -0.04171  16.760 ***  P<0.001 
            E10 vs E11               -0.01733   7.727 ***  P<0.001 
            E10 vs E12               -0.05730  22.469 ***  P<0.001 
            E10 vs E13               -0.06176  27.540 ***  P<0.001 
            E10 vs E14               -0.06358  26.833 ***  P<0.001 
            E10 vs E15               -0.06812  30.850 ***  P<0.001 
            E10 vs E16               -0.02940  13.413 ***  P<0.001 
            E10 vs E17               -0.01335   5.854  **   P<0.01 
            E10 vs E18              -0.003471   1.522  ns   P>0.05 
            E11 vs E12               -0.03998  14.969 ***  P<0.001 
            E11 vs E13               -0.04443  18.680 ***  P<0.001 
            E11 vs E14               -0.04625  18.511 ***  P<0.001 
            E11 vs E15               -0.05079  21.649 ***  P<0.001 
            E11 vs E16               -0.01208   5.181  *    P<0.05 
            E11 vs E17               0.003977   1.648  ns   P>0.05 
            E11 vs E18                0.01386   5.740  **   P<0.01 
            E12 vs E13              -0.004452   1.667  ns   P>0.05 
            E12 vs E14              -0.006273   2.258  ns   P>0.05 
            E12 vs E15               -0.01081   4.093  ns   P>0.05 
            E12 vs E16                0.02790  10.614 ***  P<0.001 
            E12 vs E17                0.04395  16.264 ***  P<0.001 
            E12 vs E18                0.05383  19.919 ***  P<0.001 
            E13 vs E14              -0.001821  0.7287  ns   P>0.05 
            E13 vs E15              -0.006362   2.712  ns   P>0.05 
            E13 vs E16                0.03235  13.879 ***  P<0.001 
            E13 vs E17                0.04841  20.051 ***  P<0.001 
            E13 vs E18                0.05828  24.143 ***  P<0.001 
            E14 vs E15              -0.004541   1.840  ns   P>0.05 
            E14 vs E16                0.03417  13.929 ***  P<0.001 
            E14 vs E17                0.05023  19.833 ***  P<0.001 
            E14 vs E18                0.06011  23.734 ***  P<0.001 
            E15 vs E16                0.03871  16.847 ***  P<0.001 
            E15 vs E17                0.05477  22.989 ***  P<0.001 
            E15 vs E18                0.06465  27.136 ***  P<0.001 
            E16 vs E17                0.01605   6.781 ***  P<0.001 
            E16 vs E18                0.02593  10.953 ***  P<0.001 
            E17 vs E18               0.009879   4.033  ns   P>0.05 
Appendix 
157 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Two-way ANOVA for left eye right eye interaction over E9-E18. The analysis suggests that left/right cornea 
has the same effect at all values measured at each developmental day (p≥0.01). It also shows that developmental 
day and cornea (left/right) account for 80.16% (p≤0.01) and 3.25% (p≤0.01) of total variance, respecitvely 
suggesting that both factors play a role in the measurement of corneal thickness.  
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2. Grey value data  
 
Grey value plots used to determine association of globular domains of type VIII collagen. 
Different peaks are produced depending on the arrangement of the globular domains. A 
parallel arrangement would produce asymmetric/double peaks as a result of stacked NC1 
domains adjacent to stacked NC2 domains. An anti-parallel association would produce large 
symmetrical peaks caused by alternate stacked NC1 and NC2 domains. The elongated 
structures measured in Descemet’s membrane in this study generated symmetrical peaks; 
hence, our model was based on an anti-parallel association. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Type VIII collagen associations based on grey value. Schematic (top) displays the possible arrangements of 
type VIII collagen within the Descemet’s membrane lattice. Parallel association results would result in double 
or asymmetric peaks formed by the large (NC1 [yellow]) and small (NC2 [orange]) globular domains, whereas 
anti-parallel associations would result in tall, wide peaks as a result of the alternating large and small globular 
domains stacking on top of one another. Selected micrographs showing the clearest elongated structures were 
selected from the tilt series and grey values were calculated using Fiji/ImageJ software. A and B show the 
different peaks obtained from the highlighted area (yellow) for each elongated structure. Scale bar=100 nm. 
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3. Buffers 
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4. Araldite Resin 
 
 
 
 
 
 
 
 
5. Staining  
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